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INTRODUCTION 
    
In the introduction we first sketch the origin of the Multi-city Study and its key objectives. The 
present report is the third Multi-city Study, covering the trends and developments of 42 cities in 
Western and Eastern Europe over the period 1991-1998. 
We continue with a brief explanation of the multi-city reporting system, which is based on annual 
city reports by members of the Epidemiology Expert Group of the Pompidou Group. The core of 
these reports is the presentation of indicator data in pre-defined formats, supplemented by a 
methodological account of the data, a description of characteristics of the city as context for an 
interpretation of the data, and an assessment of trends and developments. The introduction 
concludes with an overview of the structure of the third Multi-city Study report. 
 
 
CITY PROFILES     
The main body of this report consists of profiles of the individual cities that participated in the 
multi-city network at any time during the 1990s. Each profile starts with a short qualitative 
description of the city in terms of its geographical characteristics, history and patterns of drug 
use, drug interventions and (local) drug policy. This description provides a framework for the 
interpretation of indicator data and trends, which are presented in a standard format covering five 
domains: prevalence, treatment, health risks, drug law offences and drugs market. 
City profiles are only included if we have data for at least one three years in the reporting period 
of which one year since 1996. Following these criteria the section on city profiles includes only 31 
of the 42 cities. As the profiles by themselves are already a summary of the situation and 
developments of each city, we do not copy this information in the executive summary. Instead we 
make here some general remarks on the quality and completeness of these profiles. 
For most of the cities we can only present partial information. Many indicator data are not 
available or they are only available for one or two years, which does not allow to assess trend 
developments. Context information varies greatly between cities both in scope and detail. There 
are several reasons for the rather patchy pictures of European cities. We mention a few. 
 Participation in and contributions to the multi-city network during the 1990s has not always 
been consistent. Only a few cities have reported each year; not all cities adhered to the report 
formats demanded by the Guidelines of the Multi-city Study; some cities ended their 
participation in the mid 1990s, whereas others only joined the network in recent years. 
 Although all indicators have been conceptually developed within the multi-city network as 
relevant descriptors of the drug situation, in many cases this has not been followed by 
implementation in local data collection systems. Due to a lack of resources or organisational 
structures data are not collected at all or only at a national level without provisions to extract 
data related to the city concerned. 
 Several of the indicators were and are still “under construction”, meaning that report formats 
are still changing over time and in some cases no consensus has yet been obtained about 
definitions and preferred data collection methods. 
 Although the importance of context information for the understanding of local situations and 
developments is widely acknowledged, discussions on the nature and extent of this 
information have only started recently. In reports of the first half of the 1990s “context” is 
largely absent or mainly interpreted as a more detailed verbal description of patterns and 
trends which are (also) described in figures in the indicator tables.   
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At this point it should also be remarked that the prime objective of the multi-city network in the 
past has been the methodological development of indicators and data collection. Within this focus 
there has not been much attention to fill the gaps where sound data do not yet exist. In the 
preparation of the third Multi-city Study report we have made a first attempt to fill these gaps by 
introducing informed expert estimates (see Interpretation below). This method is still a topic of 
discussion in the Epidemiology Group and we for this reason have not included these qualitative 
estimates in the city profiles. 
Another factor that has contributed to the persistence of incomplete reporting in the multi-city 
network is the general orientation of the Epidemiology Group on description instead of analysis. 
Trends and developments at city level and across the network are traditionally inspected at face 
value; at city level in the “tour de table” presentations and discussions of individual cities during 
the meetings of the Group and across cities in the annual Synthesis Reports. 
A scientific analysis of the data collected is not only inhibited by the large number of missing 
values in indicator data and time series, but even more so by the fact that the data are not 
accessible for analysis and that the Pompidou Group has only limited resources to create a multi-
city database and to perform analyses. 
These problems have been partly solved in the framework of this report in constructing a pilot 
database of indicator data from the over 120 city reports produced in the 1990s. We have used 
this database for an analytical exercise to demonstrate the potential of the data collection (see 
Analysis below) and it is the intention that the database will be updated regularly and become 
available for the scientific community in the near future.  
 
 
INDICATOR TRENDS     
Figures and trends across Europe in the 1990s are presented in tables and thematic maps for a 
selection of indicators. Figures have been recalculated as rate per 100.000 to adjust for 
differences in population size of cities. The information is only presented when we have at least 
10 cities to compare. Apart from the obvious incompleteness of data, already discussed above, 
we can make the following general observations: 
→ The magnitude of the phenomena measured by the indicators varies considerably between 
European cities, both within Western as in Eastern Europe. 
→ Where trends can be assessed most indicators and most cities show predominantly upward 
trends in the 1990s. 
Prevalence 
Although prevalence of drug use can be considered as key information for comparisons between 
cities and implementation of drug policies and interventions, survey data are largely absent. Even 
when we have data, they are often not comparable. For only one element of prevalence –current 
cannabis use among school populations- we can present consistent recent figures, but only for 
10 cities and only for 3 cities (Amsterdam, Gdansk, Lisbon) we can assess a trend.  
Treatment 
Most cities do have treatment data and in particular data about first treatment demand. The 
quality and completeness of treatment data have been considerably improved in the second half 
of the 1990s following the elaboration of the indicator in a specific project of the Epidemiology 
Group in which 23 cities participated. In general treatment demand refers to opiate users. 
In most cities figures are rising, both for all treatment and first treatment demand. The main 
exception is Amsterdam where the trend in both cases is consistently downward over the 1990s. 
In general we can assume that treatment provision follows demand. Increasing treatment data 
therefore might indicate a growing need for treatment and an increase in problematic drug use. 
There are many reasons however to be cautious about such interpretations. 
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For several cities the trends also reflect the setting up and extension of treatment services to 
make up for the absence of appropriate services in the past. This applies in particular to cities in 
Eastern Europe where the implementation of specialised treatment interventions often only has 
started in the 1990s. Trends might also have been influenced by improvements of the data 
collection systems: in some cities treatment data of the late 1990s cover more centres than those 
of the early 1990s. Differences between first and all treatment demand figures might indicate 
such changes in coverage or extension of services, but they are also influenced by differences in 
treatment modalities. 
Finally, treatment demand figures also reflect other responses to drug problems, like a diversion 
from criminal justice interventions to treatment interventions as indicated by the correlations 
between treatment and police arrest data. 
Health 
Drug related mortality shows in many cities in the 1990s an upward trend, though there are 
positive exceptions. Recent figures vary between almost 20 (Oslo) to less than 2 (Paris, Sofia, 
St.Petersburg, Varna) per 100.000 of population. 
Injecting drug use shows a downward trend in Western Europe but an upward trend in Eastern 
Europe. In general the percentage of injectors is higher in Eastern European cities than in 
Western European cities. 
Incidence of drug related Hepatitis B increases in particular in many Russian cities, where also 
the highest incidence rates can be found. The increase might be related to better registration 
within an expanding treatment system (incidence is usually registered within a treatment setting), 
but the high relative figures as such might indicate a high level of injecting drug use combined 
with the absence of needle exchange programmes. 
Data on incidence of Hepatitis C and HIV are only collected in the multi-city network since 1997 
and at present we do not yet have sufficient data to present comparative trends. Incidence of 
Aids cases among drug users increased or remained stable over the 1990s, but due to the delay 
in sero-conversion figures and trends might not relate to actual drug use patterns in the 1990s. 
Drug law offences 
In many cities trends in police arrests for drug law offences went up in the 1990s. This applies 
however mainly to Eastern European cities. Upward trends in the total number of arrests run 
often parallel with an upward trend in arrests for consumption offences. Arrests for cannabis 
related offences have also increased, in particular in Eastern Europe. Increased trends in police 
arrest are in many cases matched by a similar trend in court convictions for drug law offences. 
Drugs market 
Market indicators are not widely available. 
In general the number of seizures are increasing or stable for all drugs. Main exceptions are 
Stockholm and Malta, where seizures tend to decrease. 
Information about the purity of drugs and prices of drugs at street level is even more rarely 
available. The information stems mostly from police sources. Consistency and reliability of the 
data can be questioned and so far the Epidemiology Group has not yet developed a commonly 
agreed method to collect this type of information.  
 
 
AGGREGATE TRENDS: EAST-WEST COMPARISONS     
Both the city profiles and the indicator trends suggest substantial differences between Eastern 
and Western European cities. We have investigated this difference in trend patterns by 
aggregating the indicator data for all cities in each of these regions. This results in a marked 
difference between the regions, both with regard to the magnitude of indicators and the trend 
orientations, which confirms general observations that drug problems in Eastern Europe emerged 
on average 10-15 years later than in Western Europe. The average figures for East and West are 
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also presented in graphic format, which shows that in most cases the gap between Eastern and 
Western Europe is rapidly closing during the 1990s. At the end of the decade the average figures 
for Eastern Europe are almost at the same level as in the West. 
Below we summarise the main differences. 
Treatment 
Higher figures for first treatment demand and non-fatal emergencies and lower figures for all 
treatment demand in Eastern Europe compared to Western Europe. Treatment demand 
indicators increased in the East, whereas in the West only all treatment demand shows an 
increase. The latter might reflect changes toward more long-term treatment modalities, e.g. 
substitution treatment.  
First treated drug users in the East are younger than in the West. The trends in East and West 
are opposite: in Eastern Europe mean age decreases, in Western Europe mean age increases. 
Health 
Higher levels of injecting drug use in Eastern Europe and increasing, whereas in the West 
injecting drug use is less common and decreasing. This is matched by the figures and trends for 
incidence of Hepatitis B. For Aids present figures do not differ very much, though in the East 
incidence is rising; this seems consistent with the later start of drug problems in Eastern Europe 
and the time lag inherent to Aids incidence as indicator of drug problems.  
Average figures for drug related mortality are about the same, but mortality is increasing in 
Eastern Europe. 
Drug law offences 
The differences in average figures between East and West are less outspoken. Arrests for 
trafficking offences increase in both regions; total arrests, consumption related arrests and 
convictions for drug law offences increase in Eastern Europe and remained stable in the West.  
Western Europe shows more arrests for cannabis related offences, which indicates a less 
widespread use of cannabis in Eastern Europe. 
Drugs market 
With the exception of heroin, Western European cities show higher numbers of drug seizures 
than Eastern European cities. Trends in the west are stable, in the East they trends are going up, 
but not for cannabis.  
 
 
ANALYSIS: RELATIONS BETWEEN INDICATORS     
As remarked above an analysis the data collection of the multi-city network is constrained by the 
large number of missing values. However, by using simple algorithms we are able to replace a 
number of missing data in time series by imputed values to obtain a dataset that allows at least 
some elementary statistical analysis. 
We have investigated the interrelations between the indicators within each domain and between 
domains. At both levels we find a large number of significant correlations. Most of these 
correlations can be easily explained and confirm common knowledge in the field. For example 
with regard to relations within indicator domains: first treatment demand correlates with all 
treatment demand (when more people enter treatment, the total number in treatment increases); 
incidence of Hepatitis B correlates with injecting drug use (injecting is main risk factor for 
infection); convictions correlate with arrests (arrests precede sanctions by the criminal justice 
system). And examples between domains: treatment indicators correlate with health indicators 
(both treatment and health indicators refer to injecting drug use; incidence of infections is usually 
first registered in treatment); treatment data correlate with arrests (e.g. due to arrest referral 
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systems); arrests correlate with drug seizures (most arrests will involve some confiscation of 
drugs). 
These relations between indicators have also been investigated separately for cities in Eastern 
and Western Europe and for large and smaller cities. The results confirm the previously found 
differences between East and West as well as the common perception that drug use and drug 
problems are typical metropolitan issues.  
The impact of this type of analysis is not only that it can add to the interpretation of trends and 
developments, but also that it can contribute to the validation of the indicators. Although each 
indicator used in the Multi-city Study has an information value by itself, the set of indicators has in 
the first place been developed to indicate and monitor abstract concepts as “the drug situation” or 
“drug problem situation”. Within this context the interrelations between the present indicators also 
point out that they measure more or less the same aspect and some might be redundant. 
Although we acknowledge the limitations of our analytical exercises on the fragmentary dataset of 
the Multi-city Study we have included them in this report to encourage and stimulate others to 
shift their focus from the continuing problems of data collection, which seem to be inherent to the 
phenomenon of drug use, towards more exploration of the limited data we do have. 
 
 
INTERPRETATION     
In the last section of the third Multi-city Study we discuss the results of an “interpretation” among 
the experts of the Epidemiology Group. As mentioned before, we have added this survey to 
address some issues that are not or incompletely covered by the city reports of the 1990s. 
Problem drug use 
In the expert survey estimates of problem drug use have been defined as users in need of 
treatment. Estimates vary from about 70 (Debrecen) to almost 1800 (Bratislava) per 100.000 of 
population. Compared with actual treatment figures (all treatment) in most cities only 10-25% of 
treatment need is assumed to be met; in Dublin and Paris this might be around 50%, in 
Amsterdam and Gdansk services might reach about 75% of the problem users. It should be 
remarked that for the last two cities the estimates of problem drug use are based on a formal 
capture-recapture model, which makes use of treatment data. 
Prevalence of drug use; new and old drugs 
The experts have been asked to rank different drug types in following order of current prevalence 
among the general population and as primary drug among problem drug users, both according to 
the situation at the end of the 1990s and in the beginning of the 1990s. Results are presented as 
pyramids of illicit drug use for Eastern and Western European cities and for smaller and larger 
cities separately. Complementary to these rank orders of prevalences at the beginning and the 
end of the reporting period we also asked the experts for perceived trend developments with 
regard to individual drugs and to label drug types as new or old drugs in comparison to the 
situation in the 1980s. 
The information provided indicates the following. 
→ Cannabis is and was the most common drug among the general population in Western 
Europe; in Eastern Europe inhalants used to be more common than cannabis, but at the end 
of the 1990s cannabis has also become the most widespread drug in the East. 
→ The traditional drugs of Eastern Europe, inhalants and opiate extracts, have been replaced 
during the 1990s by amphetamines and heroin. 
→ Heroin is both in the east and in the west the most prevalent problem drug. 
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→ Cocaine use remains in Eastern Europe of low importance; in the West it has become the 
second most common drug after cannabis. 
→ The size of cities has no influence on the relative prevalences of particular drug types. 
→ In Eastern Europe most drugs are considered more or less as new drugs compared to the 
situation in the 1980s, whereas some see opiate extracts and inhalants as old drugs. In 
Western Europe no drugs seem to have disappeared during the 1990s, but many perceive 
ecstasy and crack as newly emerging drugs. 
→ Most drugs show an upward trend, both in the East and the West. Exceptions are inhalants 
and opiate extracts. Crack cocaine is relatively often reported as not being observed. 
Epidemiological stages 
With the interpretation survey and the discussion of its results in the Epidemiology Group we 
have also attempted an exercise to explore an epidemiological model of drug use. In this model 
we distinguish five stages in the spread of psychotropic substances, which go parallel with 
increasing levels of prevalence. 
1 Endemic: drug use strongly limited to certain age-cohorts, socio-economic groups AND 
geographic boundaries. 
2 Endemic-epidemic: drug use exceeding over age-, social-, OR geographic-boundaries 
3 Epidemic: drug use spreading over different age-cohorts, socio-economic groups OR 
geographic areas 
4 Epidemic-pandemic: drug use not restricted (anymore) to clearly definable age-cohorts, 
socio-economic-groups AND geographic areas 
5 Pandemic: drug use strongly spreading over different age-cohorts, socio-economic 
groups AND geographic areas. 
The results of the survey indicate that at present cannabis use have reached stage 4 in Western 
Europe and stage 3 in Eastern Europe. The use of heroin and amphetamines might be at stage 2 
in both Eastern and Western Europe. In Western Europe cocaine and ecstasy use is also 
assumed to be in stage 2. Other drugs do not yet pass stage 1.  
As in the case of our analysis of relations between indicators, our exploration of diffusion patterns 
of drug use is only a first step towards an epidemiological model. Again, we have included the 
exercise in the third Multi-city Study report as an encouragement for further exploration. 
General local drug situations 
As a final supplement to the body of information about local developments collected and 
presented in the past decade in the multi-city network of the Epidemiology Group we have ask 
the experts to classify the participating cities on a combined problem and control scale.  
The results confirm again the general East-West divide in Europe. Most Eastern European cities 
are confronted with increasing drug problems not matched by intervention control. In Western 
Europe the experts perceive either decreasing problems or increasing problems, which remain 
however largely under control of appropriate intervention responses. 
It should be noted at the same time that there are still more cities in the East than in the West 
which do not yet have any serious drug problems at all.    
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CONCLUSIONS      
For the Multi-city Study in the 1990s the most important development has been the expansion of 
the network to Eastern European cities since the mid 1990s. In general the expansion has been 
matched by an improvement of the multi-city data collection as Eastern European cities are more 
likely to adopt the Guidelines of the reporting system as the basis of their local data collection. 
Although most of the Russian cities joined the network only in the past two years, they still 
managed to complete time series of indicator data to cover most of the reporting period. At the 
same time we notice however decreasing levels of participation from Western European cities. 
Some ended their participation, others do not manage anymore to deliver complete city reports. 
This development in Western Europe is associated with a shifting focus from local towards 
national reporting systems since the establishment of the monitoring centre of the European 
Union (EMCDDA).  
The larger number of cities in the network allows for more insight in trends and developments 
across Europe. In this report we have explored this in particular on the East-West dimension. 
On the other hand the growing number of cities also causes constraints for an inspection of 
trends. The expansion of the network has not been matched timely by changes in data collection, 
data storage and data presentation. The reporting mode –descriptive annual city reports on paper 
or in electronic form- remained largely the same. The revision of the Guidelines in 1998 did 
introduce more structure for the information to be presented, but did not result in a reduction of 
information nor in priorities regarding information. As a consequence the accessibility of the multi-
city information has decreased. Overall pictures cannot emerge from reading and inspecting at 
face value a vast number of reports, notes and indicator tables about over 40 individual cities.  
In the framework of the third Multi-city Study report we managed to make up for some of these 
complications by constructing a consistent database for the period 1991-1998. This might not 
have solved the structural problems of collection and storage of the multi-city data, but it allowed 
to present in this report comprehensive profiles of the participating cities, general overviews of 
European trends and tentative explorations of relations and developments. 
As an overall picture from the information in the network as a whole in the 1990s we observe that, 
→ The use of illicit drugs has become a persistent phenomenon in Europe; regular use might 
still be quite rare, but experimenting and incidental use has become a common aspect of 
youth cultures across Europe. Eastern Europe catching up with the West in this respect 
seems to be an inevitable effect of the processes of democratisation and opening of frontiers 
after the fall of the communist regimes in those countries.  
→ In Western Europe where illicit drug use first emerged, the negative consequences of drug 
use (service demand, health implications, criminal justice interventions) tend to stabilise; the 
increasing trends in Eastern Europe go parallel with the still increasing trends in drug use due 
to the catching with Western Europe up mentioned above. 
→ Differences in context (geography, policies, etc.) seem to have more effect on the negative 
consequences of drug use than on the level of drug use as such.  
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OBJECTIVES OF THE MULTI-CITY STUDY 
    
In 1982 the Ministerial Conference of the Pompidou Group installed the Epidemiology Expert 
Group to develop monitoring systems to evaluate the nature and magnitude of the problems 
created by drug abuse in the social and public health field. 
From the start the Epidemiology Expert Group has adopted a city-based approach and the Group 
has operated as a multi-city network. This choice was based on the argument that the city level 
would be more suitable than the national level to develop and pilot appropriate monitoring 
systems. The smaller scale of cities makes it easier to account for the context needed to interpret 
facts and trends. Another argument was that in the beginning of the 1980s drug problems were 
mainly concentrated in urban or metropolitan environments. 
Since 1983 the Epidemiology Group has presented and discussed each year a vast number of 
reports on individual cities and synthesis reports on trends across cities. These activities, which 
have become known as the Multi-city Study of the Pompidou Group, pursue the following 
objectives. 
→ To elaborate uniform methods and indicators,  which describe patterns and developments of 
drug use and problem situations related to drug use; 
→ To explore characteristics and trends of drug use and related problems, by collating and 
comparing situations and developments across cities. 
In the framework of the Multi-city Study the Epidemiology Expert Group has produced several 
reports on data collection methods and specific indicators, including accounts of scientific 
seminars about monitoring and methodological issues. This has resulted among others in a set of 
standardised indicators and report formats to monitor drug situations, which are published as the 
Guidelines of the Multi-city Study and form the basis of the annual city reports. Several of the  
indicator standards initiated and developed by the Group are today incorporated into the national 
monitoring systems of European countries and the key indicator reporting system of the 
European Monitoring centre for Drugs and Drug Addiction (EMCDDA).  
In the periodic Multi-city Study reports the Epidemiology Group summarises and integrates trends 
and developments at city level across Europe over a period of years. The first Multi-city Study 
was published in 1987 and examined the validity, relevance and comparability of a number of 
indicators to evaluate trends of drug use. This first study covered 7 main European capitals - 
Amsterdam, Dublin, Hamburg, London, Paris, Rome, Stockholm- and presented developments 
up to 1985. With the second Study, published in 1994 and reporting on trends up to 1991, the 
number of cities had increased to 13, now also including Barcelona, Copenhagen, Geneva, Oslo, 
Helsinki and Lisbon. 
The present third Multi-city Study deals with the period 1991-1998 and covers 42 cities. This 
major increase in the number of cities reflects the expansion of the scope of the epidemiological 
activities of the Group when in the 1990s most Eastern European countries joined the Pompidou 
Group and cities in those countries entered the multi-city network. Considering this development 
the third report gives special attention to differences between Western and Eastern Europe. 
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THE MULTI-CITY REPORTING SYSTEM 
    
The basic structure of the Multi-city reporting systems is set out in Guidelines that call for a 
standardised reporting. During the 1990s the Guidelines have been modified a few times and 
adapted to changing demands for information, feasibilities of data collection at city level and the 
need for more systematic reporting in order to cope with the growing number of participating 
cities. Over the years however the following topics have been the basic elements of the city 
reporting system: 
• Indicator data related to drug use and drug problems 
• Methods and data sources of indicator data 
• Context information 
• Trends and developments 
Indicator data 
The indicator data are the core of the reporting system. The Guidelines provide definitions and 
report formats for each indicator. The indicators cover the following domains. 
• Prevalence: prevalence figures based on both general population and school surveys; 
estimates of problem drug use; 
• Treatment: first and all treatment demand; opiate substitution (since 1997); needle 
exchange and distribution (since 1997); drug related non-fatal emergencies; admissions 
to general and psychiatric hospitals (until 1996) 
• Health behaviour and health risks: estimates of injecting drug use; drug related mortality; 
drug related morbidity (Hepatitis, HIV, Aids) 
• Drug law offences: arrests for drug law offences; prosecution (since 1997) and 
convictions for drug law offences; drug users in prison (until 1996) 
• Drugs market: drug seizures; prices and purity of drugs at street level 
In the 3rd revision of the Guidelines (published in 1998 and effective for data of 1997 onwards) 
some indicators have been dropped while others have been added. New indicators have been 
introduced to cover important aspects of harm reduction policies (opiate substitution and needle 
exchange) or to better monitor developments in law enforcement (prosecution). A separate 
indicator on admissions to general and psychiatric hospitals is no longer necessary as the 
treatment indictor , which previously was restricted to specialised drug treatment services, now 
covers all treatment services and modalities provided to drug users. Finally, information on drug 
users in prison is no longer included based on the consideration that data of city-based prisons in 
most cases did not relate to local drug situation. 
Methods and data sources 
In line with the methodological objectives of the Multi-city Study indicator data are supplemented 
by information about data sources, coverage of data and data collection methods. Information 
about these aspects is of crucial for the evaluation of data reliability and comparability. 
To accentuate the importance of data methodology the 3rd revision of the Guidelines introduced a 
questionnaire format to collect this information for each indicator. 
Context 
Indicator data reflect the environment in which they are collected. This context is important to 
understand data and to interpret trends in particular when indicator data are being compared 
between cities. Relevant context information may include demographic, socio-economic and 
socio-cultural characteristics of the city, local history of drug use, organisation and resources of 
intervention structures, developments in drug policy and drug laws as well as public responses 
and attitudes to drug use.  
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Although the need for context information is commonly acknowledged it remains difficult to decide 
which context information adds to a better understanding and comparability of indicator data. 
Comparative studies of drug use patterns accounting for the context of these patterns are quite 
rare. Until today most information on context is still collected in free format. Whilst this allows a 
great flexibility for the reporting expert to address aspects that might be relevant to his or her city, 
it limits comparative analysis as each expert might focus on different items. Recently the 
Epidemiology Group has started initiatives however to improve the scope and comparability of 
context information by organising interpretation workshops during its annual meetings.  
Trends and developments 
A summary of indicator trends and observations about new and disappearing trends with regard 
to specific drugs, patterns of use, risk groups and effects of drug use complete the city reporting 
system. 
Until 1998 trend information was included in the indicator dataset and almost exclusively 
restricted to observed quantitative trends, which follow from changes in indicator data. The new 
Guidelines of 1998 however focus on qualitative information about trends and developments. In 
doing so the multi-city reporting systems not only calls on the participants of the Epidemiology 
Group to present city data but also to report about the city as informed experts.  
Limitations of the reporting system 
It should be remarked that the general outline of the reporting system above is not always 
matched by the actual city reports of the past years. In reality individual city reports vary 
considerably in scope, content and detail, due to the fact that the required information is not 
always available at city level and –probably more important- because of lacking resources to 
produce comprehensive annual city reports. Also, many of the improvements introduced in the 
1998 Guidelines have not yet been accounted for in all reports presented up to date.  
It should be noticed further that the multi-city reporting system traditionally has been restricted to 
objective quantitative indicator data or estimates based on sound scientific methods. This follows 
from the key objective to focus on methodology of indicator construction and data collection. 
Although the availability of data has improved in the past decade all over the network, many cities 
still do not have data according to the standard indicators. As a consequence in most cases the 
reporting system only provides incomplete pictures of the situation and developments in cities. . 
More important, the large numbers of missing indicator data inhibit attempts to analyse patterns 
and trends across Europe.  
As this situation is not likely to change very quickly in the near future, qualitative trend information 
has already been included in the new Guidelines of 1998 and in the framework of the third Multi-
city Study report we also carried out a separate survey among the experts of the Epidemiology 
Group to supplement the available indicator data with informed expert estimates about a number 
of issues (see below). It will be a topic of discussion for the future if such type of estimates should 
be systematically included in the structure of the Multi-city study reporting system. 
  
STRUCTURE OF THE 3rd THE MULTI-CITY STUDY 
    
The third Multi-city Study report presents an integrated overview of the developments in the 
cities, which participated in the multi-city network at any time during the 1990s. We present the 
information in three different ways. 
• Section 3: City profiles 
• Section 4: European trends 
• Section 5: Analysis and interpretation 
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City profiles 
In this section we present a summary profile of the participating cities. The profiles are split into 
– context; 
– indicator data and trends.  
Context is based on the corresponding section of the underlying city reports. In most cases we 
have used the latest report available. Indicator data and trends present the most recent indicator 
data and a graphic display of trends in indicator data. As we do not consider data prior to 1996 as 
relevant recent information for a report to be published in 2000 and require for trends data of at 
least three different years in the reporting period, city profiles can only presented for 31 of the 42 
cities that participated in the network in the 1990s. 
European trends 
In this section we present trends across Europe in two different ways. 
• (4.1)  Indicator trends 
• (4.2)  Aggregate trends 
Indicator trends present for each indicator the most recent data (since 1996, see above) and the 
trends per city. To allow comparisons between cities, indicator data have been standardised as 
figures per 100.000 of population. Trend developments are assessed on the basis of a statistical 
model and presented as a simple ordinal scale of up, down and stable in table and map formats. 
In Aggregate trends we give graphic presentations of average trends in indicators (again 
standardised as rates per 100.000 of population) in Eastern and Western European cities. This 
choice to compare East and West at aggregate level is based on the observation in 4.1 of clear 
differences in the magnitude of indicator rates between Eastern and western European cities and 
also accounts for the change in the scope of the Pompidou Group in the 1990s caused by the 
joining of Eastern European countries. 
Analysis and interpretation  
We conclude the report with a tentative attempt to analyse and interpret trends in the multi-city 
network in the 1990s. We call this a tentative attempt as we have to acknowledge that the data 
collection of the multi-city study does not really meets all requirements for scientific (statistical) 
analysis, mainly due to the large number of missing values, both across cities and years included 
in the time series 1991-1998. This section is divided into 
• (5.1)  Analysis 
• (5.2)  Interpretation  
In Analysis we investigate the interrelations between the indicators of the reporting system. For 
this analysis we have tried to overcome the shortcomings of the multi-city data collection by the 
imputation of missing data in time series of individual cities.  
Interpretation deals with an exploration of trends and developments, which until now cannot really 
be covered by the data collection of the multi-city study but are considered to be key topics for 
future development of the multi-city reporting system. The exploration is based on a survey and 
subsequent discussions among the experts of the Epidemiology Group in 1999. It addresses the 
following issues: 
 problem drug use and in particular the question to which extent service needs are matched 
by service provision  
 changing patterns of prevalence and the emergence or disappearance of particular drug 
types 
 epidemiological stages in drug use 
 general assessment of local drug situations 
 21
Following the observations of section 4 about differences between Eastern and Western Europe 
we try in both the Analysis and Interpretation to differentiate in developments and situations 
between East and West. 
We realise that the methods applied in section 5 may cause scientific critics and discussion. We 
believe nevertheless that the exercises presented, even within the constraints of limited and 
imperfect data, can contribute to further elaboration of relevant and meaningful reporting in the 
complex field of drug use and can stimulate others to use indicator data to develop explanatory 
models. 
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CITY PROFILES 
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ACCOUNT OF DATA PRESENTATION 
In this chapter we present profiles of cities on which the experts of the Epidemiology Group have 
reported in the period 1991-1998. Each profile consists of two sections: 
• Context information 
• Indicators and trends 
The purpose of the profiles is to provide a quick overview of trends in the 1990s, recent indicator 
data and context information. The information presented is a very summarised selection of city 
reports delivered by the experts in the 1990s. The selection also reflects the fluctuations in the 
participation of cities in the Multicity network. Some cities ended their participation in the 1990s, 
others have joined the network and many cities did not present (complete) reports each year.  
  
Context information 
Understanding trends in indicator data requires information on the context in which these trends 
emerge. Although the need for this type of background information has been acknowledged in the 
Multicity network from its beginning, context information is often neglected due to the network’s 
focus on indicator data and associated data collection problems. In the first half of the 1990s 
context information was largely absent in the city reports. After the introduction of the New 
Guidelines in 1997, which include an array of specific questions on context, most city reports do 
include context information, but they also reveal that we do not yet have clear concepts about 
scope, detail and relevance of such information. As a consequence the level of available context 
information varies considerably between cities.   
Here we present for each city in abstract form and as far as available information on: 
• Geography 
• History and patterns of drug use 
• Drug interventions and policy 
The topic geography intends to cover demographic, socio-economic and related aspects, but 
remains in most cases very rudimentary. With regard to history and patterns of drug use and 
interventions we have tried to avoid duplication of information that in principle can also be read 
from the indicator and trends.  
 
Indicators and trends 
All indicator values refer to 1998 unless otherwise indicated in italics next to the figures. However, 
the cut-off point for ‘recent’ data has been set arbitrarily at 1996; if the latest available figure 
dates before 1996 no data are presented. 
Trends are presented in graphic format, but only if we have at least 3 annual figures for one of 
the data included in graph. Trend graphs however do cover data prior to 1996. 
As a consequence of these selection criteria we only include profiles for 31 of the 42 cities that 
participated in the Multicity network at any time in the period 1991-1998. 
For simplicity legends have been omitted in trend graphs. Bars and lines correspond to the items 
listed in the adjacent indicator tables and match the colour of the boxes next to these items.  
The trend graphs only intend to present relative developments of the indicator data at city level 
and not to ‘read’ actual figures. The X-axis corresponds in all cases to the time series 1991-1999, 
but the scales of the Y-axis can vary between graphs and across cities. The trend graphs 
therefore do not allow comparisons with regard to the magnitude of different indicators of one city 
nor with regard to the magnitude of identical indicators across different cities. 
 
Multicity network 1991-1998 
The following map and table gives an overview of the cities that have participated in the Multicity 
network in the period 1991-1998. The table also marks for which cities profiles are included and 
lists the names of the epidemiology experts who prepared the original city reports. 
In two cases city profiles have been replaced by a country profile: Albania because of current 
problems in data collection at local level, and Malta because the urban area and population more 
or less coincides with the country as whole.  
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Overview of cities participating in the Multicity network 1991-1998 
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Overview of cities participating in the Multicity network 1991-1998 
city country profile included authors of city reports in the 1990s 
ALBANIA Albania  Eduard Kakarriqi, Z.Sulaj 
AMSTERDAM Netherlands  Peter Cohen, Ruud Bless, Steven Diemel e.a. 
ATHENS Greece  Anna Kokkevi, Kyriaki Politikou 
BARCELONA Spain  Teresa Brugal, Joan Caylà, Luis Torralba 
BRATISLAVA Slovak Republic  Alojz Nociar 
BRUSSELS Belgium  Mark Vanderveken 
BUDAPEST Hungary  Eva Katona, Katalin Veress,   
CHARLEROI Belgium  Benoît De Clerk 
COPENHAGEN Denmark  Elisa Dall, Dorrit Schmidt 
DEBRECEN Hungary  Zsuzsa Varsavovski 
DUBLIN Ireland  A.O’Hare, K.O’Higgins, Mary O’Brien e.a.  
FRANKFURT Germany  Oliver Müller 
GDANSK Poland  Jacek Sekiewicz 
GENEVA Switzerland  Dominique Hausser, Isabelle Renschler 
GLASGOW United Kingdom  Martin Frischer 
HAMBURG Germany  K.J.Lange 
HELSINKI Finland  Osmo Kontula 
JEKATERINBURG Russia  J.Ruzhnikov 
KALININGRAD Russia  V.Amenitsky 
KEMEROVO Russia  A.Seledtsov 
KRASNODAR Russia  V.Kolesnikov, I.Koikova 
LIEGE Belgium  Luc Bils, Isabelle Noirfalisse e.a. 
LISBON Portugal  Luisa Rodrigues, C.Antunes, Z.Mendes e.a. 
LJUBLJANA Slovenia  Dusan Nolimal, T.Jerman, Miljana Vegnuti e.a. 
LONDON United Kingdom  Richard Hartnoll, Paul Griffith e.a.  
MADRID Spain  Plan Municpal sobre las Drogas 
MALTA Malta  Richard Muscat 
MOSCOW Russia  Eugenia Koshkina, A.Shamota 
NOVOSIBIRSK Russia  R.Terkulov 
ORENBURG Russia  Andrej Karpets, V.Karpets 
OSLO Norway  Astrid Skretting 
PARIS France  M.Toussirt, R.Ingold, F.Facy, A.Toufik e.a. 
PERM Russia  S.Elovikov, V.Sokolov 
PRAGUE Czech Republic  Ladislav Csémy 
ROME Italy  Ustik Avico, Laura Camoni e.a. 
SOFIA Bulgaria  Philip Lazarov 
STOCKHOLM Sweden  Börje Olsson 
ST.PETERSBURG Russia  Galina Korchagina, Y.Vasiliev 
SZEGED Hungary  Károly Zelenai, György Talabér 
VARNA Bulgaria  Gueorgui Popov 
WARSAW Poland  Janusz Sierolawski, Antoni Zielinski e.a. 
YAROSLAVL Russia  V.Melnikov 
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ALBANIA Context 
 
 
Population: 3,249,000 (1995) 
  
Geography 
Until 1912 Albania was a very poor and very rural province of the Ottoman Empire. It gained 
independence in 1912. In 1944 it became a communist state. Communism in Albania took an 
extreme Stalinist form, which led to international isolation. The victory of democracy in 1992 
marked an opening towards free movement of ideas and people. However, the situation 
remained and remains fragile. In 1997 Albania experienced much social unrest and internal 
armed conflicts. The country is still in a process of demographic, social and economic transition. 
Albania is rapidly changing from a rural into an urban society. Population pressure is noticeable in 
the coastal plains. The population of the capital Tirana increased from 350,000 in 1994 to 
700,000 in 1998. Emigration, virtually non-existent until 1989, is a conspicuous phenomenon 
during the 1990s. Birth rate and infant mortality resemble those of developing countries, life 
expectancy however is comparable with developed countries. In similar way morbidity patterns, 
with communicable diseases at first place, are typical for developing countries whereas mortality 
represents epidemiological patterns of a developed country. 
Albania’s economy completely collapsed in the early 1990s. The economic reforms initiated in 
1992 paved the way of a recovery, but at high social costs. The GDP of $ 766 in 1996, though 
much higher than the $ 213 of 1992, is the lowest of all European countries. Unemployment is 
high, especially among the youth. Participation in education declined in the 1990s due to an 
increasing number of dropouts related to the establishment of family businesses and farms at the 
introduction of a market-economy, internal migration and emigration. 
The unrest and turmoil of 1997 aggravated the overall social-economic situation. Organised crime 
appeared, including networks of drug dealers. The prominent changes in the political and 
economic arena also brought about changes in social life and traditional values.  
 
History and patterns of drug use 
In the years before 1993 drug use and drug problems were sporadic insignificant phenomena in 
Albania. Since there is an exponential increase, especially following the conflicts of 1997. Today 
there is an established drugs market in the country. 
 
Drug interventions and policy 
In Albania still exists only one specialised centre for both inpatient and outpatient treatment, the 
Toxicological Clinic of Tirana University Hospital Centre (TUHC). The Psychiatric Clinic of the 
same TUHC does not deal with drug treatment. 
There are two structures of drug law enforcement: the most important is the Anti-Drug Unit of the 
Ministry of Public Order (Ministry of Interior); the other is the Anti-Drug Unit of the National 
Directory of Customs (under the Ministry of Finances).  
In the new Penal Code of the Republic of Albania (1996) traffic, production and sales of illicit 
drugs are considered as punishable penal acts and criminal offences against the public order and 
public security. Sanctions can go up to prison terms of 15 years.  
Since 1996 there is National Committee against Drugs, composed by the ministers of all the 
ministries involved in the drugs fight. Also a National Centre of Drugs Information Systems has 
been created. 
 29
Indicator data and trends ALBANIA 
 
 
 PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 334 1997
All treatment
Mean age
first treatment % < 25 65.6% 1997
first treatment % females 7.8% 1997
HEALTH
Injecting drug use Prevalence of IDU
Estimated IDU prevalence 33.8% 1997
reference: first treatment
Infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B
Hepatitis C
HIV 0 1997
Aids
DRUG LAW OFFENCES
Arrests for drug law offences Arrests
Trafficking 477 1996
Consumption
Total arrests
DRUGS MARKET
Drug seizures Number of seizures
Cannabis
Heroin 9 1996
Cocaine 3 1996
Amphetamines
Ecstasy
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AMSTERDAM Context 
 
 
Population: 727,000 (1999) 
 
Geography 
Capital of the Netherlands (but not the seat of the government). Amsterdam is an international 
financial, commercial, tourist and cultural centre. Nearby Schiphol is one of the main European 
airports. The city has several centres for higher education, including two universities. About 45% 
of the population is of non-Dutch origin. 
  
History and Patterns of drugs use 
In the late 1960s cannabis and LSD were introduced when the city was a centre of alternative 
subcultures. In the early 1970s the first users of heroin and amphetamines appeared. Users (and 
dealers) of Surinamese origin played a major role in the widespread diffusion of ‘chasing the 
dragon’ (inhaling the vapours) among the Dutch heroin-using population. Together with the rapid 
response of accessible methadone provision this route of administration probably contributed to 
the consistent relatively low number of drug-related deaths. After a peak in the mid-1980s, a 
steady decrease of the numbers of heroin users can be observed.  
The use of cannabis is widely accepted. Amsterdam has many so-called ‘coffee-shops’ where 
cannabis can be purchased in small quantities for personal use. This is tolerated within the Dutch 
legal system and originates from a policy to split the markets of hard drugs and soft drugs. 
Parallel to the emergence of new dance subcultures in the 1990s, ecstasy has become the 
second most popular illicit drug after cannabis among the youth population. In the late 1990s 
experimental use of new (semi-legal) drugs such as psychedelic mushrooms increases. 
In the late 1990s the use of crack cocaine has also established among some groups of street 
drug users. 
 
Drug interventions and policy 
Low-threshold provision of methadone started in the late 1970s. Today the majority of heroin 
users participate in methadone substitution programmes. Methadone is provided by specialised 
agencies as well as local GPs; it is also delivered to addicted arrestees at police stations and in 
prisons.  
During the AIDS epidemic in the 1980s syringe exchange programmes have been initiated. The 
Municipal Department of Public Health operates several special programmes for subgroups of the 
drug using population (addicts admitted to general hospitals, prostitutes, homeless users), provides 
back-service to methadone prescribing GPs and participates in an experiment of heroin 
prescription to long-term poor-functioning heroin users. The Jellinek Centre is the main institute 
for outpatient and inpatient treatment and care.  
Amsterdam has a central system of monitoring drug users in treatment and care. Since the early 
1990s the Jellinek Centre also maintains a monitoring system (Antenna) on drug use among 
young people. 
Dutch municipalities have executive powers to develop their own local drug policies. The 
Amsterdam drug policy for the last twenty years has a dual focus on both public health (harm 
reduction) and public order (nuisance reduction). There is an active coordination between actors 
and actions in the domains of public health, specialised drug services, police and justice. As the 
municipality finances almost all drug services, budget allocation is a major policy instrument. 
Another important policy instrument is the wide application and enforcement of local by-laws to 
reduce drug related nuisance.  
 
 
 
 
 
 
 31
PREVALENCE
Cannabis use general population school population Cannabis prevalence  Problem drug users
Ever (LTP)
Recent (LYP) 13.4% 1997
Current (LMP) 8.3% 1997 23.0% 1997
Problem drug use
Prevalence estimate 5018
TREATMENT
Treatment demand
First treatment 472
All treatment 2018
first treatment Mean age 30.1
first treatment % < 25 9.1%
first treatment % females 24.8%
Opiate substitution First and all substitution Mean age and % < 25  % females
First substitution 203
All substitution 3053
first treatment Mean age 34.2
first treatment % < 25 14.8%
first treatment % females 27.6%
Hospital episodes Non fatal emergencies
Psychiatric hospitals
General hospitals
Non-fatal emergencies 603
HEALTH
Injecting drug use Drug related deaths
Estimated IDU prevalence 20.5%
reference unknown
Mortality
Drug related deaths 25
Infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B
Hepatitis C
HIV
Aids 10 11.8% 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 1571
Consumption 1228
Total arrests 2799
Convictions for drug law offences
Total convictions 892 1996
DRUGS MARKET
Drug seizures Number of seizures Drug prices
Cannabis 437 1999
Heroin 555 1999
Cocaine 1243 1999
Amphetamines 102 1999
Ecstasy 328 1999
CAN
OTHER
Indicator data and trends AMSTERDAM 
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ATHENS Context 
 
 
Population: 3,073,000 (1991) 
 
Geography 
Capital of Greece. In the administration Athens only exists as Greater Athens, a conglomeration 
of 55 municipalities, including Piraeus, the main port of Greece. The process of massive 
urbanisation and population growth of the 1970s has been reduced to a moderate pace in the 
1990s. Greater Athens is the main commercial and industrial centre of Greece. Tourism also 
plays an important role in Athens’ economy. According to the 1991 census the unemployment 
rate was 8.4%. This figure might have increased in recent years. Apart from being the economic 
centre of Greece, Athens is a great cultural, intellectual and artistic centre.  
 
History and Patterns of drugs use 
Illicit drug use was very limited until the 1970s and mainly confined to certain sections of the 
working-class population. There was a significant increase in illicit drug use from the mid-1970s, 
which spread widely into various socio-economic groups. Since the late 1970s the use of drugs, 
especially opiates and licit psychotropic substances, started spreading among younger age 
groups. The use of non-prescribed psychoactive drugs was rather high because the legal status 
of their prescription was not well defined until the mid-1980s, but it has decreased since. 
Although cannabis is the most widespread illicit drug, survey data show that among the general 
population the highest prevalences are still found for (non-prescribed) psychoactive medicines 
(tranquillisers, barbiturates, antidepressants, etc.). Among pupils aged 14-18 years solvents are 
more popular than cannabis. Heroin is the most prevalent drug among dependent individuals. 
The sharp increase of drug-related deaths in the mid-1990s might be a delayed consequence of 
the spread of the heroin epidemic since the mid-1980s as well as a result of the high prevalence 
of injecting. It is estimated however that in the second half of the 1990s injecting drug use is 
decreasing. 
 
Drug interventions and policy 
Up to 1983 in-patient detoxification was the most important service, but today a wide variety of 
services are in place. The first national law (1987) that dealt thoroughly with the problem of 
expanding drug use considered the drug dependent as a ‘patient’ instead of a criminal and 
covered all aspects of the problem with an emphasis on ‘de-stigmatisation’. Consecutive laws 
have strengthened this policy by setting up more intervention services and structures and by 
introducing more severe penalties for trafficking. Provisions have been made for counselling 
centres, prevention services as well as facilities for monitoring the drug situation. 
The law of 1993 legalised substitution treatment in special units and created the Greek 
Organisation for Combating Drugs (OKANA), a private sector organisation under the Ministry of 
Health with executive powers to coordinate programmes, in which local authorities, specialised 
agencies, police and justice participate. The law of 1995 placed particular emphasis on therapy, 
introducing the postponement of the penal prosecution of drug law offenders provided that they 
have voluntarily entered and systematically attended treatment. Further refinements to the 
intervention strategies were made in a law of 1998. 
A first opiate substitution programme started in Athens in 1996. It has been expanded in 1998 
and further expansion is foreseen. Streetwork and syringe exchange appeared in 1997.  
Since 1996 there is a debate among professionals and politicians on a legal distinction between 
soft and hard drugs and the expansion of methadone programmes. 
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PREVALENCE
Cannabis use general population school population
Ever (LTP)
Recent (LYP)
Current (LMP) 2.5% 8.2%
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 300
All treatment 687
first treatment Mean age 34.1
first treatment % < 25 38.0%
first treatment % females 18.7%
Opiate substitution
First substitution 91
All substitution 314
first treatment Mean age 40.0
first treatment % < 25 3.3%
first treatment % females 17.6%
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 52.2% 1997
reference: first treatment
Mortality
Drug related deaths 239
Infectious diseases incidence in IDU % IDU infected
Hepatitis B
Hepatitis C
HIV
Aids 3 3.6% 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests  Convictions
Trafficking
Consumption
Total arrests 4580 1997
Convictions for drug law offences
Total convictions
DRUGS MARKET no (recent) data
Indicator data and trends ATHENS 
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BARCELONA Context 
 
 
Population: 1,509,000 (1995) 
 
Recent context information is not available; the latest report including a general description of the 
local situation however dates from 1992. The city operates since the late 1980s an elaborated 
and consistent drug information system. In the past Barcelona has provided detailed annual 
indicator data reports for the Multicity network, but the city ended its participation in 1996. For the 
purpose of the 3rd Multicity Study the project coordinator nevertheless received additional 
indicator data for 1997. 
 35
PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 1362 1997
All treatment 3468 1997
first treatment Mean age 28.0 1997
first treatment % < 25 34.8% 1997
first treatment % females 22.0% 1997
Hospital episodes Non fatal emergencies
Psychiatric hospitals
General hospitals
Non-fatal emergencies 3028 1997
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 41.5% 1997
reference: all treatment
Mortality
Drug related deaths 122 1997
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B
Hepatitis C
HIV
Aids 162 1997
DRUG LAW OFFENCES no (recent) data
DRUGS MARKET no (recent) data
Indicator data and trends BARCELONA 
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BRATISLAVA  Context 
 
 
Population: 451,000 (1995) 
 
Geography 
Capital of the Slovak Republic, located near the Austrian and Hungarian borders. Commercial, 
industrial and cultural centre of the country. Unemployment rates in the 1990s: 4-6%. 
 
History and Patterns of drugs use 
Until the late 1980s illicit drug use was a hidden phenomenon, probably limited to some small 
groups. Since 1989 Bratislava gradually became a transit point of trafficking in psychoactive 
substances. In the 1990s cannabis and heroin use spread among young populations. Problem 
drug use shifted from pharmaceutical drugs to heroin. In 1993 treatment demands of 
predominantly young heroin users dramatically rose. Treatment capacity expanded and in 1997 
their number is more than tenfold of 1992. 
Today cannabis is the main illicit drug. Surveys indicate increasing lifetime prevalence rates for 
all types of drugs. According to school survey data solvents/inhalants and sedatives/tranquillisers 
are the most popular drugs after cannabis. Most heroin users are still very young. Because of the 
high prevalence of injecting and needle sharing, there is a growing fear for the spread of HIV and 
Hepatitis B and C among users in the future. 
 
Drug interventions and policy 
Up to 1990 treatment for drug users was provided by the Anti-alcohol Counselling Centre, but 
specialised treatment, health and social care services and prevention programmes for drug users 
have been developed since. In 1994 a small programme of needle exchange was started and 
continued and drug prevention at schools was introduced. In 1997 the first methadone 
programme was initiated. 
In 1995 the National Programme for Combating Drugs was established, which operates by a 
system of regional and districts commissions. In 1994 the Act Against Organised Crime was 
introduced and articles on drug production, trafficking and possession in the Penal Code were 
revised. Since 1998 a new law on psychoactive substances is in force and a Law on Precursors 
will soon be approved. The drug legislation leads in some circumstances to the criminalisation of 
drug users, although the consumption of drugs is not penalised. 
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PREVALENCE
Cannabis use general population school population
Ever (LTP)
Recent (LYP)
Current (LMP) 3.9% 8.5%
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 362
All treatment 1026
first treatment Mean age 21.9
first treatment % < 25 34.8%
first treatment % females 30.9%
Opiate substitution
First substitution
All substitution 140
all treatment Mean age 21.8
% < 25
all treatment % females 22.9%
HEALTH
Injecting drug use
Estimated IDU prevalence 77.9%
reference unknown
Mortality
Drug related deaths 18
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 6 1997
Hepatitis C
HIV 0.7% 1997
Aids 0 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence  Convictions
Trafficking 490 1997
Consumption 4 1997
Total arrests 494 1997
Convictions for drug law offences
Total convictions 496
DRUGS MARKET
Drug seizures
Cannabis 22
Heroin 79
Cocaine 4
Amphetamines 2
Ecstasy 1
Indicator data and trends BRATISLAVA 
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BUDAPEST Context 
 
 
Population: 1,886,000 (1998) 
 
Geography 
Capital city of Hungary. Commercial, industrial and cultural centre of the country. Growing tourist 
industry with rapid proliferation of bars, discos and other entertainment centres. Unemployment 
rate: 5%. Due to the economic crisis real income has significantly decreased in the 1990s. 
 
History and Patterns of drugs use 
In the second half of the 1960s inhalants were the most common used substances among young 
people. By the end of the 1970s the drug scene consisted of poly-drug users of inhalants, 
alcohol, and pharmaceutical drugs. Since the 1980s opiates such as home made preparations of 
the poppy plant and heroin, followed by stimulants, are the most common drugs in the scene. In 
the 1990s illicit drug use is increasing among several subpopulations. Increased drug use goes 
parallel with the developing market economy, economic crisis, confusing health care reform, 
flimsy social networks. Growing supply and the emergence of new youth subcultures increased 
the use of cannabis and ecstasy among youngsters, while volatile substances remain popular. 
Abuse of pharmaceutical drugs remains widespread too, partly due to liberal rules regarding the 
prescription of medicines. The use of ‘Polish kompot’ (homemade opiate extract) is diminishing. 
Homeless young adults using solvents have been identified as a new risk group.  
 
Drug interventions and policy 
Budapest has a variety of treatment facilities, covered by the national health care system. In 
general, treatment is aimed at abstinence. Since 1989 methadone is prescribed in detoxification 
but there are no official methadone maintenance programmes. In the 1990s low-threshold care 
facilities and projects have been developed. A needle exchange programme was started in 1995. 
In 1994 a mobile Drug Prevention Bus was initiated, aimed at youngsters, parents and teachers. 
A sift towards a medical-social perspective on drug use led to a revision of the drug legislation in 
1993. This includes more severe penalisation of trafficking and related crimes, while for drug 
users (abstinence oriented) treatment instead of imprisonment can be considered. Today’s 
national drug policy balances supply and demand reduction. Attitudes and views of police and 
treatment system have become less polarised. Only recently local policy making is developing, 
but still lacking the framework of a coherent national strategy. At present the Budapest local 
government attempts to evaluate the drug situation and to prepare an integrated Action Plan 
aiming at both care provision to crime prevention. In recent years drug use has become a topic of 
public concern and debate. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment  % females
First treatment 2982
All treatment 4569
Mean age
all treatment % < 25 53.9%
first treatment % females 35.5%
Opiate substitution
First substitution 156 1997
All substitution 384 1997
all treatment Mean age 24.0 1997
first treatment % < 25 71.8% 1997
first treatment % females 32.7% 1997
Hospital episodes Non fatal emergencies
Psychiatric hospitals
General hospitals
Non-fatal emergencies 1626
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 26.0% 1997
reference: all treatment
Mortality
Drug related deaths 207 1997
infectious diseases incidence in IDU % IDU infected
Hepatitis B 4.4% 1997
Hepatitis C 15.6% 1997
HIV 0.0% 1997
Aids 0.0% 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests Arrests by drug  Convictions
Trafficking
Consumption
Total arrests 292 1997
Convictions for drug law offences
Total convictions 49
DRUGS MARKET
Drug seizures Number of seizures
Cannabis 1283
Heroin 423
Cocaine 132
Amphetamines 720
Ecstasy 123
CAN
OTHER
1997
Indicator data and trends BUDAPEST 
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COPENHAGEN Context 
 
 
Population: 488,000 (1997) 
 
Geography 
Capital city of Denmark. National and international centre of transport, industry, tourism and 
culture. Gateway to the other Scandinavian countries. Unemployment: 11.7% (1997) but figures 
are decreasing. Positive economic development in the 1990s.  
 
History and Patterns of drugs use 
In the 1960s recreational use of cannabis and hallucinogens started to spread among young 
people, first among musicians, artists and other alternative subgroups, in the late 1960s among 
students. Survey data show that lifetime prevalence of cannabis in 1990 was lower than twenty 
years before. Cannabis and amphetamine use has been stabilised but there is an overall 
increase in illicit drug use in the 1990s, in particular of ecstasy and cocaine. The first opiate users 
were found among the young experimenting generation of the early 1970s but remained limited to 
small marginalized groups. In the 1970s and 1980s Copenhagen had high figures for drug-related 
deaths and prevalence of infectious diseases. In the mid-1990s 'chasing the dragon' was 
introduced as an alternative for injecting heroin. During the 1990s the HIV and AIDS epidemic 
declined, though Hepatitis C is now widely spread among drug users. 
 
Drug interventions and policy 
Since the late 1960s a number of specialised inpatient treatment facilities and projects for social 
reintegration of drug users were established. Drug prevention projects for schools and special 
risk groups were initiated in the 1970s and 1980s. In the second half of the 1980s drug treatment 
and care was expanded by setting up outpatient services, the provision of methadone, the 
development of outreach services and free delivery of needles and syringes. Many drug users 
received methadone from GPs, but since 1996 this practice is not allowed anymore. 
Drug treatment took place in the social and educational sphere and not in hospitals. In the 
second half of the 1990s the treatment system became more differentiated, serving many 
services aimed at various target groups. Since 1997 voluntary treatment in prison was set up. In 
1996 general practitioners were not allowed anymore to treat drug users by themselves. 
Until the mid-1980s intervention was based on a drug-free treatment strategy. The policy has 
become more harm reduction oriented since and the treatment system more diversified. The 
current municipal programme pursues the double aim of a drug free society and harm reduction. 
In general treatment, prevention and general social care for drug users are seen as more 
important instruments than police interventions and public prosecution. The city has a co-
ordination structure in which local authorities, drug agencies, police and justice are represented.  
The Swiss heroin programmes have got a lot of attention in Denmark and provoke an ongoing 
debate about the national drug policy and the integration of heroin prescription in treatment. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 240 1997
All treatment 1583 1997
first treatment Mean age 31.7 1997
first treatment % < 25 20.0% 1997
first treatment % females 24.0% 1997
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 15.0% 1997
reference: all treatment
Mortality
Drug related deaths 73 1997
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 5 1997
Hepatitis C
HIV
Aids 5 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence
Trafficking 266 1997
Consumption 5609 1997
Total arrests 5875 1997
DRUGS MARKET no (recent) data
Indicator data and trends COPENHAGEN 
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DUBLIN Context 
 
 
Population: 916.000 (1991) 
 
No context information available. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 871
All treatment 3357
first treatment Mean age 21.7
first treatment % < 25 76.2%
first treatment % females 32.1%
Opiate substitution
First substitution
All substitution 3600
HEALTH
Injecting drug use Drug related deaths
Estimated IDU prevalence 35.3% 1996
reference: all treatment
Mortality
Drug related deaths 136
infectious diseases incidence in IDU % IDU infected Incidence in IDU  % IDU infected
Hepatitis B
Hepatitis C
HIV
Aids
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence
Trafficking 1250
Consumption 1691
Total arrests 2941
DRUGS MARKET
Drug seizures Number of seizures Drug prices
Cannabis 4513
Heroin 884
Cocaine 151
Amphetamines 680
Ecstasy 466
Indicator data and trends DUBLIN 
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GDANSK Context 
 
 
Population: 756.000 (1998) 
 
Geography 
Major port city of Poland on the Baltic Sea. Major centre of industry (shipbuilding, chemical 
industry), commerce, culture and tourism. Positive economic development in the 1990s. 
Unemployment rate decreased from 13.2% in 1992 to 3.1% in 1997. 
 
History and Patterns of drugs use 
In the late-1960s drug use was observed among subgroups of youngsters using non-prescribed 
pharmaceutical drugs, cannabis and solvents. It was estimated that during the early 1970s the 
city counted about 300 problem drug users of pharmaceuticals and/or opiates. In the mid-1970s a 
new technological development led to the production of ‘Polish heroin’, which was cheap and 
relatively easy accessible, and a new wave of users of this illicit substance was observed. Drug 
use then stabilised between 1985 and 1989. Along with the transition from a ‘closed’ to an ‘open’ 
society in the 1990s, the use of cannabis, inhalants, amphetamines and new drugs such as 
ecstasy increased among young subpopulations. Cocaine use is relatively rare, but in 1996 the 
first cocaine users entered the treatment system. 
Today, cannabis is the most common illicit drug, followed by amphetamines, LSD, solvents, 
ecstasy, cocaine and (Polish) heroine. In the general population prevalence of non-prescribed 
sedatives and tranquillisers comes second after cannabis. The drug problem population 
predominantly consist of (injecting) users of Kompot or home made ‘Polish heroin’, who also use 
other drugs and alcohol. Heroin use seems to stabilise, whereas amphetamine use seems to 
increase among problem users. Since 1997 the introduction of ‘brown sugar’ or ‘brown powder’, 
the smoking of heroin in a cigarette, not uncommonly mixed with marihuana, is observed in clubs 
among young subgroups. 
 
Drug interventions and policy 
Until 1980 the drug problem did officially not exist in Poland. The first treatment centres in the city 
–the Drug Rehabilitation Centre and an outpatient clinic for drug users– were established in 1981. 
A number of (specialised) inpatient and outpatient treatment facilities have been established in 
the city since, including clinics for HIV/AIDS patients, a majority of them being drug users. Drug 
users in treatment undergo detoxification in the Psychiatric Hospital before being accepted to one 
of the residential centres. In the late-1980s and the 1990s several other medium-/high-threshold 
programmes for drug users were initiated in the city: rehabilitation programme for drug users in 
prison (1986), a syringe and needle exchange programme (1989), drug prevention projects 
aiming at the general public, specific risk groups, schools, workplaces, support programmes for 
families of drug users and HIV-infected users, outreach services, etc. 
At local level the drug policy is coordinated by the Gdansk Advisory Council. The Council defines 
drug strategies in which all levels of governmental and non-governmental organisations work 
effectively together to reduce harm associated with the use of illicit drugs. 
The police combat drug-related crime at several levels. At the level of city districts they 
concentrate on small and medium-level dealing, drug use and other crimes. At city level the 
Gdansk District Command of Police deals with major drug trafficking. Customs and the Prison 
Anti-Drug Division control respectively the port and airport and the city prison. 
In 1997 the Polish Parliament adopted the Law on Strategies to Counteract Drug Dependence to 
replace the law on the prevention of drug dependence of 1985. The new law provides the legal 
grounds for taking more decisive action to reduce the supply and demand of illicit drugs, similar to 
the legal regulations implemented in other European countries, and balances prevention and 
treatment with severe penalties of drug-related offences. Drug users can be compulsory send to 
treatment centres for rehabilitation. The philosophy behind this is not to force users with rules or 
requirements, but to establish conditions in which the individual will develop his/her personality 
and to maintain a place in society. A recent initiative in Gdansk drug policy is the incorporation of 
drug treatment in open health care structures. 
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PREVALENCE
Cannabis use general population school population Cannabis prevalence  Problem drug users
Ever (LTP)
Recent (LYP)
Current (LMP) 8.7% 1997
Problem drug use
Prevalence estimate 2630
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 366
All treatment 1323
first treatment Mean age 18.7
first treatment % < 25 98.6%
first treatment % females 25.7%
Hospital episodes Non fatal emergencies
Psychiatric hospitals
General hospitals
Non-fatal emergencies 598
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 96.2%
reference unknown
Mortality
Drug related deaths 46
infectious diseases incidence in IDU % IDU infected Incidence in IDU  % IDU infected
Hepatitis B 31 34.0%
Hepatitis C 38 38.0%
HIV 235 32.0%
Aids 10 0.8%
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 39
Consumption 109
Total arrests 191
Convictions for drug law offences
Total convictions 64
DRUGS MARKET
Drug seizures Number of seizures Drug prices
Cannabis 428
Heroin 371
Cocaine 5
Amphetamines 37
Ecstasy 17
CAN
OTHER
Indicator data and trends GDANSK 
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GENEVA Context 
 
 
Population: 401.000 (1997) 
 
Geography 
Located in the French speaking area of Switzerland on the French border. International city.  40% 
of the population is of foreign origin. Geneva is the seat of several UN institutions and other 
international organisations. Important financial centre. Unemployment rate: 6.8% (1996). 
 
History and Patterns of drugs use 
Drugs (cannabis, opiates) first appeared in the city in the 1970s. Drug use increased in the 
1980s, in particular the use of heroin. Injecting became the common route of heroin 
administration. 
 
Drug interventions and policy 
Until the mid-1980s police interventions were the main response of the city to the drug problem. 
From the end of the 1980s however emerged a medicalisation of the drug problem due to the 
health risk associated with intravenous drug use. Following extensive political and public debates 
about intervention approaches, in particular after the city of Zurich closed its “open drug scene”, a 
diversified system of treatment and care facilities has been established. This includes methadone 
substitution and participation in the Swiss programme of controlled prescription of heroin.   
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 160 1997
All treatment 656 1997
first treatment Mean age 27.7 1997
first treatment % < 25 32.0% 1997
first treatment % females 15.0% 1997
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 34.4% 1997
reference: first treatment
Mortality
Drug related deaths 31 1996
Infectuous diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 1 1997
Hepatitis C
HIV
Aids 22 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 78 1996
Consumption 1752 1996
Total arrests 1830 1996
Convictions for drug law offences
Total convictions 393 1996
DRUGS MARKET
Drug seizures Number of seizures
Cannabis 1330 1997
Heroin 250 1997
Cocaine 189 1997
Amphetamines 3 1997
Ecstasy
CAN
OTHER
1996
Indicator data and trends GENEVA 
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HAMBURG Context 
 
 
Population: 1.708.000 (1996) 
 
Geography 
Main seaport of Germany located near the North Sea at the river Elbe. Unemployment about 13% 
in 1997. Cultural centre with a tradition of active alternative subcultures. 
 
History and Patterns of drugs use 
After a peak of the incidence of heroin users in the early 1990s, it seems that their number is 
stabilising or possibly decreasing. Until 1995 the total number of heroin/problem drug users in the 
city was officially estimated at 10000 (which is probably an overestimation), in subsequent years 
this number decreased. In 1997 the size of the population of problem drug users is estimated 
between 7000 and 8000. They are predominantly intravenous heroin users. 
In the 1990s cannabis use became widespread among young adults, while the new drug ecstasy, 
often associated with juvenile ‘rave’ and ‘techno’ dance scenes, has become the second popular 
illicit drug. Cocaine use appears to rise since 1995 among drug users on the street as well as 
among ‘non-deviant’ subpopulations.  
 
Drug interventions and policy 
Hamburg has a wide variety of intervention structures, including several low-threshold centres 
and programmes. Needle exchange programmes and methadone substitution are available since 
1995. 
The Hamburg drug policy is harm reduction oriented. Criminal prosecution is mainly directed at 
trafficking. In the 1990s visible drug markets (“open scenes”) at the central railway station, in park 
areas and specific districts caused major public concern and debate about drug related nuisance 
and intervention strategies. 
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PREVALENCE
Problem drug use
Prevalence estimate 7500 1997
TREATMENT
Treatment demand First and all treatment  % females
First treatment 2795 1996
All treatment 5013 1996
Mean age
% < 25
first treatment % females 32.0% 1996
Hospital episodes Hospital admissions Non fatal emergencies
Psychiatric hospitals 1324 1997
General hospitals 487 1997
Non-fatal emergencies 1500 1996
HEALTH
Injecting drug use Drug related deaths
Estimated IDU prevalence 90.0% 1996
reference: all treatment
Mortality
Drug related deaths 127 1997
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B
Hepatitis C
HIV
Aids 9 1996
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 4584 1997
Consumption 8657 1997
Total arrests 13241 1997
Convictions for drug law offences
Total convictions 1354 1996
DRUGS MARKET
Drug seizures Number of seizures
Cannabis 740 1997
Heroin 1505 1997
Cocaine 566 1997
Amphetamines
Ecstasy
CAN
OTHER
1997
Indicator data and trends HAMBURG 
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HELSINKI Context 
 
 
Population: 539.000 (1998) 
 
Geography 
Capital of Finland. National centre of commerce and industry. 
 
History and Patterns of drugs use 
Traditionally illicit drugs are much less used than other intoxicants like alcohol and medicines. In 
the early 1990s only 1% of services dealing with dependency problems concerned drug related 
problems. Drug use might have increased since but known figures partly reflect more intensified 
police control following the revision of the Narcotics Act in 1994. Cannabis is the most common 
illicit drug used among the general and school population. Compared to cannabis use, the use of 
other illicit drugs is relatively low. The intoxicant use of barbiturates and sedatives, in particular in 
combination with alcohol, is a more common problem. Surveys data show that illicit drug use is 
much higher in Helsinki than elsewhere in Finland.  
 
Drug interventions and policy 
Treatment services in Finland are for a large part oriented to alcohol abuse or the mixed use of 
alcohol and medicines. Since 1987, the Drug Withdrawal Unit of the Helsinki University Central 
Hospital is the only facility specialised in treatment of drug users within the health care system.  
The Narcotics Act of 1994 implied some decrease in the penalisation of use-related offences, but 
drug use as such continued to be a punishable act. Police investigations on drug-related offences 
have intensified since. The national programme initiated by the Ministry of Social Affairs and 
Health includes elements of harm reduction, but the focus remains on repressive control at street 
level. No changes in the current legislation are foreseen. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment
First treatment 335 1996
All treatment
Mean age
% < 25
% females
Hospital episodes Hospital admissions
Psychiatric hospitals 360
General hospitals 28
Non-fatal emergencies
HEALTH
Mortality Drug related deaths
Drug related deaths 14
DRUG LAW OFFENCES
Arrests for drug law offences Arrests Arrests by drug
Trafficking
Consumption
Total arrests 1967
DRUGS MARKET no (recent) data
CAN
OTHER
Indicator data and trends HELSINKI 
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KALININGRAD Context 
 
 
Population: 421.000 (1996) 
 
Geography 
Kaliningrad is a big non-freezing port, linked with the Baltic see by means of a deep canal. It 
serves as the base of a large fishing and transport fleet. The region of Kaliningrad, bordered by 
Lithuania and Poland is isolated from the rest of the territory of Russia. In recent years the 
population has increased due to migration, but natural growth is negative with death rates 
exceeding birth rates and a decrease of general life expectancy.  
 
History and Patterns of drugs use 
Since the mid 1990s heroin is replacing homemade opiates in the local drug market. Kaliningrad 
has the highest prevalence of HIV infection of all Russia. HIV was first observed in 1996 but 
spread rapidly since, mainly due to transfer of the virus through sharing needles to inject drugs, 
though an exact figure cannot be provided. On the other hand incidence of Hepatitis B and drug 
related mortality decreased. 
 
Drug interventions and policy 
Drug related emergencies decreased in recent years. Treatment demand remained stable of the 
past years. Police arrests also decreased. There are no signals however that trends in these data 
indicate a decrease in drug consumption. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 190
All treatment 1517
first treatment Mean age 25.7
first treatment % < 25 37.8%
first treatment % females 20.5%
Hospital episodes Non fatal emergencies
Psychiatric hospitals 42
General hospitals
Non-fatal emergencies 31
HEALTH
Injecting drug use Drug related deaths
Estimated IDU prevalence 86.6% 1997
reference: all treatment
Mortality
Drug related deaths 12
infectious diseases Incidence in IDU
incidence in IDU % IDU infected
Hepatitis B 27
Hepatitis C
HIV
Aids 2
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 627
Consumption 481
Total arrests 1108
Convictions for drug law offences
Total convictions 503
DRUGS MARKET
Drug seizures Number of seizures Drug prices
Cannabis 234
Heroin 60
Cocaine
Amphetamines 20
Ecstasy
CAN
OTHER
Indicator data and trends KALININGRAD 
 
 
 54 
KEMEROVO Context 
 
 
Population: 480.000 (1998) 
 
Geography 
Kemerovo is situated in the southern part of Western Siberia. It is a regional industrial centre with 
chemical, oil-chemical, power and metallurgical industries. The area has both declining and 
growing industries. There is a considerable shortage of proper housing. The city received in the 
1990s many migrants, displaced persons from former Central Asia Soviet republics. At the same 
time many inhabitants left the city adding to the general picture of demographic transition. 
 
History and Patterns of drugs use 
From the end of 1970s opiates and cannabis derivatives began to be brought into Kemerovo from 
Kirgizia and Kazakhstan. Drug trafficking is mainly carried out by residents of former Central Asia 
Soviet republics. On the market opiates, cannabis derivatives, and ecstasy (and look-alikes) 
prevail. Heroin use is increasing and in general availability of all drugs has increased. 
 
Drug interventions and policy 
The city operates several specialised drug services. Non-governmental organisations and private 
practioners also provide treatment and care, they are not covered by official statistics however. 
Drug policy is implemented by the Regional and City Health Departments. The Kemerovo region 
also has a coordination council for the struggle against drug addiction that involves all domains. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 854
All treatment 1192
first treatment Mean age 20.7 1997
first treatment % < 25 51.9%
first treatment % females 23.2%
Hospital episodes Hospital admissions
Psychiatric hospitals 418
General hospitals
Non-fatal emergencies 514
HEALTH
Mortality Drug related deaths
Drug related deaths 76
infectious diseases Incidence in IDU
incidence in IDU % IDU infected
Hepatitis B 197
Hepatitis C 78
HIV
Aids 7
DRUG LAW OFFENCES
Arrests for drug law offences Arrests  Convictions
Trafficking
Consumption
Total arrests 1137 1997
Convictions for drug law offences
Total convictions 549 1997
DRUGS MARKET
Drug seizures Drug prices
Cannabis
Heroin
Cocaine
Amphetamines
Ecstasy
Indicator data and trends KEMEROVO 
 
 
 56 
KRASNODAR Context 
 
 
Population: 768.000 (1996) 
 
Geography 
Situated in the South of Russia near the border with Georgia. In the 1990s Krasnodar has 
obtained a frontier zone status with several territories of the former USSR. Military activities in 
these regions (Georgia, Armenia, Chechnya) resulted in large numbers of migrants from these 
regions, which are not accounted for in official statistics. The actual population might at present 
exceed 1 million. The official demographic figures show similar trends as elsewhere in Russia: 
decreasing birth rates, increasing infant mortality and increased general mortality.  
 
History and Patterns of drugs use 
The use of all sorts of drugs increased in the 1990s. Frontier position, instable demographic 
situation and the refugee problem all favour the increase of drug use and related problems. In 
recent years trends remain partly hidden as dependent users tend to seek help from private 
clinics (established since 1992), which are not covered by local statistics. Illegal drugs can easily 
enter the region from neighbouring countries. Many drugs are being delivered through seaports of 
the Kuban province (Novorossijk, Sochi, Tuapse). Cannabis is also grown locally. Besides police 
confiscations indicate an increase of half-synthetic and synthetic preparations such as pervitin, 
methadone, MDMA, LCD etc. Administration of homemade opium in syringes is one of the main 
channels of the spreading of HIV-infection among addicts. 
 
Drug interventions and policy 
Treatment demands increased in the early 1990s, but remained relatively stable in later years. 
This is connected with the diversion of drug users to private clinics, where they are not registered. 
The number of admissions into specialised psychiatric hospitals increased but admissions to 
general hospitals have decreased. The latter might also be caused by errors in diagnostics. 
At regional level in 1998 a coordinated programme to counter abuse of drugs and illegal 
trafficking has been approved. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 1980
All treatment 5734
first treatment Mean age 22.2 1997
first treatment % < 25 51.2%
first treatment % females 12.3%
Hospital episodes Hospital admissions Non fatal emergencies
Psychiatric hospitals 805
General hospitals 168
Non-fatal emergencies 409
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 85.0%
reference: first treatment
Mortality
Drug related deaths 35
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 51
Hepatitis C
HIV
Aids 31
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 121
Consumption 1675
Total arrests 1796
Convictions for drug law offences
Total convictions 1796
DRUGS MARKET no (recent) data
CAN
OTHER
1997
Indicator data and trends KRASNODAR 
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LISBON Context 
 
 
Population: 1.836.000 (1991) 
 
Geography 
Capital city of Portugal. Main centre of transport, commerce, industry and culture. In 1997 the 
unemployment rate was 7%. 
 
History and Patterns of drugs use 
From the mid-1970s till the mid-1980s illicit drug use was limited to cannabis. From the mid-
1980s onwards there has been a sharp increase in heroin use. In recent years the number of 
heroin users seem to be stabilise, while cocaine use became the second problem drug. In the 
late 1990s both the use and availability of ecstasy and amphetamines increase as well. The 
increase in treatment demand is related to the growth of both the number of problem users and 
treatment facilities. In the 1990s cannabis use as well as the use of new drugs such as ecstasy 
and amphetamines increased. 
 
Drug interventions and policy 
In the mid-1970s the first specialised drug treatment and primary prevention service was 
established in the city. In the 1990s the number of treatment facilities and programmes has 
expanded, now including day-centres for drug users, treatment facilities in prison and AIDS 
prevention programmes. Needle exchange is available since 1993. In 1994 the first methadone 
maintenance programmes were established. In 1997 the national government expanded the 
network of the state-operated Centres for Drug Treatment throughout the country and improved 
support to private organisations to increase activities on prevention and treatment. The state 
centres are more targeted on outpatient treatment, whereas the private ones are more targeted to 
inpatient treatment. Psychotherapy and socio-therapy are the main treatment approaches.  
In 1998 the national government appointed a Commission of Experts to propose a national 
strategy to combat illicit drugs. Local drug policies focus mainly on primary prevention.  
Since the 1970s drug use is seen as a major medical and psychosocial problem. Intervention 
focuses both on law enforcement and on the availability of (voluntary) treatment and (primary) 
prevention. At present depenalisation of the use and possession (for personal use) of drugs and 
the expansion of substitution maintenance programmes are topics of public and policy debate.
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PREVALENCE
Cannabis use general population school population Cannabis prevalence
Ever (LTP)
Recent (LYP)
Current (LMP) 6.3%
TREATMENT
Treatment demand First and all treatment
First treatment 2173
All treatment 53192
Mean age
% < 25
% females
HEALTH
Mortality Drug related deaths
Drug related deaths 212
infectious diseases incidence in IDU % IDU infected Incidence in IDU  % IDU infected
Hepatitis B
Hepatitis C
HIV
Aids 228 63.2%
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 1062
Consumption 1033
Total arrests 2095
Convictions for drug law offences
Total convictions 1083
DRUGS MARKET
Drug seizures Number of seizures Drug prices
Cannabis 630
Heroin 967
Cocaine 510
Amphetamines 0
Ecstasy 13
CAN
OTHER
1997
Indicator data and trends LISBON 
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LJUBLJANA Context 
 
 
Population: 288.000 (1997) 
 
Geography 
Capital of Slovenia. National centre of finance, trade, transport and industry. Unemployment 
rapidly increased since late 1980s, in 1997: 10.8%. 
 
History and Patterns of drugs use 
From the late 1960s to the mid-1970s solvents, cannabis, LSD, tranquillisers and painkillers were 
popular among a few 'alternative' groups. In this period there was limited experimentation with 
heroin. Injecting drug use was rare. In the late 1970s, small 'deviant' groups started to inject 
opiates. Since the late 1980s the incidence and prevalence of (injection) heroin use increased, 
while the average age of the heroin-using population decreased. Cocaine has been introduced 
among a considerable number of drug users in the early 1990s. In the mid-1990s ecstasy 
became popular among young people. Today the main illicit drugs used are cannabis, LSD, 
ecstasy, heroin, cocaine and amphetamines. School surveys indicate that sedatives are more 
common among youngsters than any illicit drug other than cannabis. 
 
Drug interventions and policy 
Ljubljana has 12 specialised treatment centres, ranging from psychiatric and non-psychiatric 
hospitals, day-care treatment centres to therapeutic communities. Inpatient facilities provide 
detoxification and drug-free rehabilitation programmes. A non-residential methadone substitution 
programme started in 1991. The self-help organisation Stigma operates a needle exchange 
programme. Centres for Social Work provide social care and organise prevention programmes. 
Local drug policy coincides with national policy. Since 1992 operates an Inter-ministerial 
Committee for Fight against Drugs which is responsible for defining policies and coordinates 
interventions. The policy is based on harm reduction. Treatment centres cooperate in a Health 
Service Network. The Ministry of Health is involved in the preparation of new legislation on the 
classification and regulation of the cultivation, production and trade of illicit psychotropic 
substances and precursors. In the penal system the use of illicit drugs is not penalised. 
Possession of small quantities of drugs is a petty offence. 
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PREVALENCE
Problem drug use
Prevalence estimate 700 1997
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 145 1997
All treatment 270 1997
first treatment Mean age 23.2 1997
first treatment % < 25 71.0% 1997
first treatment % females 24.0% 1997
Hospital episodes Hospital admissions Non fatal emergencies
Psychiatric hospitals 45 1996
General hospitals 0 1996
Non-fatal emergencies 98 1997
HEALTH
Mortality Drug related deaths
Drug related deaths 10 1997
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 0 1996
Hepatitis C
HIV
Aids 2 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence
Trafficking 223 1997
Consumption
Total arrests
DRUGS MARKET no (recent) data
Indicator data and trends LJUBLJANA 
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MALTA Context 
 
 
Population: 378.000 (1995) 
 
Geography 
Malta is an island state situated in the middle of the Mediterranean Sea, sixty miles south off 
Sicily. Valletta is the capital and major port. The economy mainly relies on tourism (1 million 
visitors each year), to some extent supported by small and medium industries. The 1990s have 
resulted in the development of a service and financial sector. Unemployment rate: 5.1% (1998). 
 
History and Patterns of drug use 
The appearance of drug use among young adults can probably be ascertained to have taken it 
roots during the early to mid 1970s. At that time this phenomenon was mainly related to the use 
of pharmaceutical products such as tranquillisers (anxiolytics), sleeping pills, dieting and codeine 
preparations along with cannabis smoking and inhalants within a limited cohort. Such behaviour 
may be mainly attributed to the Malta-London link. During the 1980s intravenous heroin use had  
also made it presence felt. The early 1990s were really punctuated by a rapid increase in the use 
of a number of drugs that coincided with the relatively new found wealth within the country. Drug 
use was now out in the open and to this day features prominently within the media, be it 
newspapers, radio or television. The turn of the century has been marked by an increase in 
stimulant use, most notably ecstasy. 
 
Drug interventions and policy 
The treatment for drug use in the early 1980s was entirely the domain of  health professionals 
and as such confined to psychiatrists operating from the only mental hospital on the Island. In 
1985 however Caritas Malta opened a rehabilitation centre and in 1987 the Government opened 
an outpatient detoxification unit (methadone & clonidine) within the grounds of the national 
general hospital. An inpatient unit soon followed in 1989. The Government rehabilitation unit was 
opened in 1992; and 1994 heralded the arrival of the National Drug Agency (Sedqa), which took  
responsibility for the three Government units. Sedqa has since developed community based 
programmes, a prison based facility and an extensive prevention programme in schools. Recent 
developments include maintenance therapy (methadone), the introduction of naltrexone and an  
accompanying programme (Stima), a needle distribution system through the health centres and a 
secondary prevention unit. 
In the field of jurisdiction, Malta has acceded to the 1988 United Nations Convention against Illicit 
Trafficking in Narcotic Drugs and Psychotropic Substances. A bill has also been passed through 
parliament to include psychotropics as well as the conventional narcotics. 
In 1994, The Prevention of Money Laundering Act was passed. In the same year the Dangerous 
Drug Ordinance of 1939 was also amended to include to include coerced treatment and a more 
complete definition of a trafficking offence. These positive changes in the law following those of 
1986, in which stiffer penalties for drug traffickers were introduced along with the  freezing and 
forfeiture of assets, are a serious attempt to limit illicit trafficking and are fully supported by the 
public at large.  
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PREVALENCE
Cannabis use general population school population
Ever (LTP) 7.0%
Recent (LYP) 5.1%
Current (LMP) 2.7%
Problem drug use
Prevalence estimate 3700 1997
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 134 1999
All treatment 797 1999
first treatment Mean age 24.7 1999
first treatment % < 25 59.0% 1999
first treatment % females 16.0% 1999
Opiate substitution
First substitution 239 1997
All substitution 741 1997
Mean age
first treatment % < 25 66.1% 1997
first treatment % females 14.6% 1997
Hospital episodes Non fatal emergencies
Psychiatric hospitals
General hospitals
Non-fatal emergencies 132 1999
HEALTH
Injecting drug use Drug related deaths
Estimated IDU prevalence 6.0% 1997
reference: first treatment
Mortality
Drug related deaths 8 1999
infectious diseases incidence in IDU % IDU infected
Hepatitis B 2 1997 1.8% 1997
Hepatitis C 48 1997 8.7% 1997
HIV 0 1997 0.0% 1997
Aids 0 1997 0.0% 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug
Trafficking 129 1999
Consumption 333 1999
Total arrests 462 1999
DRUGS MARKET
Drug seizures Number of seizures
Cannabis 94 1999
Heroin 52 1999
Cocaine 27 1999
Amphetamines 0 1999
Ecstasy 24 1999
CAN
OTHER
1999
Indicator data and trends MALTA 
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MOSCOW Context 
 
 
Population: 8.630.000 (1998) 
 
Geography 
Capital of the Russian Federation. One of the biggest European metropolitan areas. Situated in 
the centre of the European part of Russia. Transport junction with 5 airports, 7 railway stations, 2 
river ports. Moscow has a diversified industry. Centre of government and commercial services. In 
recent years decrease in industrial production and investment and increase in social problems. 
Demographic characteristics: aging population, negative natural increase, decreasing number of 
permanent residents, increasing number of immigrants. Moscow is the seat of the Russian 
Academy of Sciences, the Academy of Medical Sciences, many scientific research institutions, 
more than 100 higher educational institutions. It is also a major centre of cultural life. 
 
History and Patterns of drugs use 
For a long time the use of drugs and other psychoactive substances in Moscow was considerably 
less than in Russia on the whole. Apparent drug use –as indicated by first treatment demands- 
increased after the 1985 repressive anti-alcohol legislation. Not only because of increasing use 
but also because the anti-alcohol campaign had promoted a broadening of the network of 
institutions that provide treatment and care for addictions in general. At present the level of drug 
use in Moscow exceeds the average for Russia. Among drug users the persons of younger age 
prevail, the rate of female users continues to grow. Indices of drug related morbidity and mortality 
are increasing. Saturation of the illegal market with drugs and their wide availability are seen as 
the main causes of the sharp increase of use. Drug injecting also increases. 
 
Drug interventions and policy 
Moscow has 2 day-and-night hospitals and 11 day-hospitals for addiction treatment. Besides 
treatment can be provided in psychiatric hospitals and toxicology departments of general 
hospitals. 
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PREVALENCE
Cannabis use general population school population
Ever (LTP)
Recent (LYP)
Current (LMP) 3.5% 1999
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 10617
All treatment 20371
Mean age
first treatment % < 25 27.9% 1997
first treatment % females 18.5%
Hospital episodes Hospital admissions
Psychiatric hospitals 10077
General hospitals
Non-fatal emergencies
HEALTH
Mortality Drug related deaths
Drug related deaths 285
infectious diseases incidence in IDU % IDU infected
Hepatitis B
Hepatitis C 1842
HIV
Aids 17
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug
Trafficking 482
Consumption 7687
Total arrests 8169
DRUGS MARKET
Drug seizures Number of seizures
Cannabis 1720
Heroin 5823
Cocaine 76
Amphetamines 61
Ecstasy
CAN
OTHER
Indicator data and trends MOSCOW 
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NOVOSIBIRSK Context 
 
 
Population: 1.399.000 (1998) 
 
Geography 
Major town in Western Siberia on the river Ob. Important transport junction. Heavy industries, 
large military industrial complex, several scientific-research institutions. Demographic features: 
growth of mortality, lowering of birth rate, many citizens of foreign origin, persons without 
citizenship and displaced persons from areas with traditional drug use. High level of 
unemployment in connection with the reduction of production outputs, worsening of socio-
economical situation.  
 
History and Patterns of drugs use 
Drug use is widespread. There is a great variety of drugs on the market and availability is 
increasing. Opiates, cannabis, cocaine, amphetamines and ephedron prevail. According to data 
of school surveys, near 15% of school pupils use drugs; among first-year students of high 
schools prevalence of any drug is near 20%. Intravenous injection of drugs is practiced by over 
80% of addicts. 
Increase of drug use among young people is observed. Heroin and methadone increasingly 
replace other opiate products. Intranasal use of heroin is spreading. Continued upward trends of 
drug use and drug related problems are expected. 
 
Drug interventions and policy 
A wide range of treatment and care facilities have been established, in particular since 1995. 
Demands for treatment and care for drug related diseases and emergencies increase. Recently a 
new local programme on prevention of addictions among youngsters has been approved. There 
is a confidential telephone help-line for drug problems and there are active social organisations of 
parents against drugs. Novosibirsk has an inter-sectorial coordinating body involving all domains 
in drug intervention. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 1023
All treatment 5697
Mean age
first treatment % < 25 13.4%
first treatment % females 15.1%
Hospital episodes Hospital admissions Non fatal emergencies
Psychiatric hospitals 700
General hospitals 383
Non-fatal emergencies 413
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 83.0%
reference: all treatment
Mortality
Drug related deaths 77
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 327
Hepatitis C 121
HIV 0.5% 1997
Aids 18
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence  Convictions
Trafficking 1163 1997
Consumption 1459 1997
Total arrests 4900
Convictions for drug law offences
Total convictions 3413
DRUGS MARKET
Drug seizures Number of seizures Drug prices
Cannabis 879 1997
Heroin 4 1997
Cocaine 2 1997
Amphetamines 1 1997
Ecstasy
Indicator data and trends NOVOSIBIRSK 
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ORENBURG Context 
 
 
Population: 527.000 (1998) 
 
Geography 
The town is situated in the Southern Ural region at the southern boundary of the central part of 
Russia, at border with Kazakhstan where Europe meets Asia. It’s a junction of transport 
communications between Russia and Central Asian countries. The town has a relatively young 
population. Persons aged less than 30, make 43% of the total. Socio-demographic situation is 
characterized by a decrease of natality, increase of mortality and an increase of the flow of 
displaced persons from the ex-USSR countries. Forced migration into the Orenburg region is 
caused by the political and socio-economical changes and the worsening of inter-nations 
relations in the former USSR countries in the last decade. As much as 68.000 refugees were 
officially registered in the Orenburg region in the period 1992–1998. The majority of these forced 
migrants are Russians. At the same time there is also substantial emigration from the region, in 
recent years emigration has exceeded immigration. Overall, the demographic situation in the last 
decade has been quite unstable, which affects the social fabric of the city. 
Historically, the population of the city is multinational. Russians prevail, but there are Tatars, 
Bashkirs, Kazakhs, Tadjiks, Ukrainians, Germans, etc. as well. In recent years inter-nation 
tension was growing. 
Due to its advantageous geographical position Orenburg is a big industrial centre of the Ural 
economic region. It’s a multi-profile industrial conglomeration, where branches of heavy, light and 
food industries are combined. The production of the Orenburg gas complex is exported to many 
regions of Russia and abroad. Following the privatisation of state enterprises the economic 
situation has worsened. There are an increasing number of unprofitable enterprises (42% 
according to 1996 data). The volume of industrial production decreases. Combined with the 
general monetary crisis in Russia standards of living are continuously falling down.  
 
History and Patterns of drugs use 
According to official statistical data, the rate of individuals, taken on register due to systematic 
abuse of psychoactive substances was 17-18 per 100,000 in the mid 1980s. It increased slowly 
to up to 37 in 1995. But in the last 3 years the rate has increased very quickly and in 1998 it 
reached 305. Results of special investigations indicate that use of drugs, especially opiates, in 
the mass of the population spreads quickly. If in the beginning of 1990s drug users had usually 
been unemployed individuals with a criminal past or affiliation, but in the last 2-3 years drug use 
spread among students of higher education institutions and into middle and higher social classes 
of the population.  
During the last decade the range of drugs consumed has also changed. In 1997 heroin appeared 
on the Orenburg market and from mid-1998 it began to spread swiftly. Users switched from 
homemade opiates made of poppy straw first to the solution of raw opium and later to heroin. 
Since 1997 also cocaine, LSD and ecstasy came on the market. The changes also led to 
increased intravenous drug use and an increase in associated health problems. 
 
Drug interventions and policy 
Following increased prevalence, treatment demand and drug related medical interventions 
increased substantially. Most are related to heroin use. In the 1990s service provision has been 
diversified to cope with increasing drug use and drug related problems.  
There is a coordinating body at regional level for development and evaluation of intervention 
strategies, including representatives of all relevant domains. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 624
All treatment 900
first treatment Mean age 22.2
first treatment % < 25 73.6%
first treatment % females 6.1%
Hospital episodes Hospital admissions Non fatal emergencies
Psychiatric hospitals 134
General hospitals 52
Non-fatal emergencies 627
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 83.0%
reference: all treatment
Mortality
Drug related deaths 45
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 100 7.7%
Hepatitis C
HIV 2 0.2%
Aids
DRUG LAW OFFENCES
Arrests for drug law offences Arrests Arrests by drug  Convictions
Trafficking 29
Consumption
Total arrests 789
Convictions for drug law offences
Total convictions 639
DRUGS MARKET
Drug seizures Number of seizures Drug prices
Cannabis 338
Heroin 364
Cocaine 0
Amphetamines 3
Ecstasy 0
CAN
OTHER
Indicator data and trends ORENBURG 
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OSLO Context 
 
 
Population: 495.000 (1997) 
 
Geography 
Capital of Norway. National centre of commerce, transport, culture and tourism. Unemployment 
rate: 4% (1997). In the 1990s rather good economic development and employment situation. 
 
History and Patterns of drugs use 
Cannabis is the main illicit drug used, followed by amphetamines, ecstasy, cocaine and heroin. In 
the 1990s experimental use of cannabis and to a lesser extent other drugs such as ecstasy and 
LSD seems to increase among young adults. Problem drug use is mainly related to heroin, 
amphetamines and benzodiazepines. Injecting is the main route of heroin administration, but 
smoking of heroin is becoming more common. Heroin use stabilised in the second half of the 
1990s. This population as a whole is ageing, and there is probably no increase in the incidence of 
young people in the group of injecting users. 
 
Drug interventions and policy 
Since the 1970s several specialised facilities have been developed: inpatient centres, including a 
therapeutic community, outpatient centres, units in hospitals, ospitals and low-threshold services. 
A needle distribution programme started in 1988. Syringes are handed out by a mobile Aids Info 
Bus. In the 1990s the availability of drug free treatment facilities has grown. In 1993 a new law 
introduced compulsory treatment for drug users aged 18 and over. A pilot methadone project was 
initiated in Oslo in 1994 as a high-threshold maintenance programme conducted in close 
cooperation with inpatient and outpatient drug free treatment facilities. In 1997 the Norwegian 
Parliament decided to expand methadone maintenance by making it nationwide available for drug 
users who meet to a set of criteria. 
Local drug policy is carried out along the same lines as the national drug policy. At city level drug 
agencies and the police frequently cooperate on drug-related issues.  
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment
First treatment
All treatment
Mean age
% < 25
% females
Opiate substitution
First substitution 50 1997
All substitution
first treatment Mean age 37.0 1997
first treatment % < 25 0.0% 1997
first treatment % females 44.0% 1997
Hospital episodes
Psychiatric hospitals
General hospitals
Non-fatal emergencies 1255 1997
HEALTH
Mortality Drug related deaths
Drug related deaths 95 1997
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 28 1997
Hepatitis C
HIV 4 1997
Aids 4 1997
DRUG LAW OFFENCES
Convictions for drug law offences
Total convictions 2084 1997
DRUGS MARKET
Drug seizures Number of seizures
Cannabis 1547 1997
Heroin 1466 1997
Cocaine 94 1997
Amphetamines 833 1997
Ecstasy 138 1997
Indicator data and trends OSLO 
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PARIS Context 
 
 
Population: 2.131.000 (1995) 
 
Geography 
Capital of France. International centre of commerce, industry (car industry), culture and tourism. 
Multi-ethnic cosmopolitan city. Economic activities are shifting from industries to services with job 
losses in the early 1990s, but improving situation later on. Unemployment rate: 10.9% (1996). 
   
History and Patterns of drugs use 
Since the 1960s cannabis, LSD, amphetamines, cocaine and heroin are used. In 1989 use of 
‘crack’ cocaine was observed for the first time. From 1993 onwards the use of ecstasy and other 
synthetic drugs (GBH, ketamine e.a.) increased along with the new youth (party) cultures. Survey 
data show a marked increase of illicit drug consumption in the 1990s. This applies also for the 
use of ‘crack’ cocaine. The main route of administration of heroin is injecting, but sniffing and 
smoking of heroin is gradually increasing. The illegal (and intravenously) use of Subutex 
(buprenorphine), a substitution drug for the medical treatment of heroin users introduced in 1995, 
seems to increase. For many years Rohypnol was a common used medical drug among heroin 
users. The use of heroin probably is decreasing. 
 
Drug interventions and policy 
Drug treatment is provided by hospitals and specialised treatment centres. Drug prevention 
projects at schools were initiated in 1990.  In 1992 a pilot needle exchange programme aimed at 
reducing the risk of HIV transmission was introduced in one arrondissement of the city. In 1993 
the programme was expanded to other arrondissements. In 1995 a new government was 
launched to improve health care for drug users. The number of specialised units in clinics and 
hospitals was expanded, the distribution of substitution drugs was introduced and two low-
threshold community centres –a drop-in centre for drug users and a shelter for homeless users– 
were set up. Substitution drugs for the medical treatment of heroin users are Subutex and 
methadone. Substitutions are prescribed by local GPs. Methadone provision demands urine 
testing, prescription of Subutex does not.  
Local drug policy is carried out in line with national drug policy. At city level there is coordination 
between the police, general health care, justice authorities and the educational system. The 
decrease of injecting among heroin users has to some extent led to fewer nuisances perceived 
by the public and possibly a less negative attitude towards drug users. 
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PREVALENCE
Cannabis use general population school population Cannabis prevalence
Ever (LTP) 25.7% 1997
Recent (LYP)
Current (LMP) 23.0%
Problem drug use
Prevalence estimate 40000
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 2529
All treatment 2640 1997
first treatment Mean age 33.0 1997
first treatment % < 25 11.1% 1997
first treatment % females 27.0% 1997
Opiate substitution
First substitution
All substitution 2671
Mean age
% < 25
% females
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 18.0%
reference: all treatment
Mortality
Drug related deaths 38
Infectuous diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B
Hepatitis C
HIV
Aids 77 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 621
Consumption 3128
Total arrests 3749
Convictions for drug law offences
Total convictions 1630
DRUGS MARKET
Drug seizures Number of seizures
Cannabis 1810
Heroin 384
Cocaine 420
Amphetamines 11
Ecstasy 51
CAN
OTHER
Indicator data and trends PARIS 
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PERM Context 
 
 
Population: 344.000 (1996) 
 
Geography 
Perm is an industrial centre in the Western Ural region. It’s is a big railway junction on the way 
from Asia to Europe. Population is slowly increasing due to the influx of displaced persons from 
CIS countries and refugees from Asia. 
 
History and Patterns of drugs use 
Most illicit drugs have been observed in the city. Intravenous taking of drugs increased. Drug use 
tends to start increasingly at younger ages. A 1998 survey of 870 students in one of industrial 
areas of the town indicates, that 9.8% of them used drugs once a week or more often. In 
professional schools 22% of students have used drugs incidentally, 8% of the latter have abused 
drugs once a week or more often. Drug supply is mainly from Middle Asia and Afghanistan. 
 
Drug interventions and policy 
Steady growth of registered persons with the diagnosis «addiction» is observed. The same 
applies to drug related first aid and medical aid in hospitals. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment
First treatment 524
All treatment 5327
Mean age
% < 25
first treatment % females 11.0% 1996
Hospital episodes Hospital admissions Non fatal emergencies
Psychiatric hospitals 1168
General hospitals 575 1997
Non-fatal emergencies 1650
HEALTH
Mortality Drug related deaths
Drug related deaths 24
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 450 1997
Hepatitis C
HIV
Aids 21
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence  Convictions
Trafficking 1285
Consumption 1756
Total arrests 3041
Convictions for drug law offences
Total convictions 1918
DRUGS MARKET no (recent) data
Indicator data and trends PERM 
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PRAGUE Context 
 
 
Population: 1.207.000 (1998) 
 
Geography 
Capital city of the Czech Republic. National centre of transport, commerce, industry, culture and 
tourism. Positive economic development in the 1990s. Rapid expansion of third sector services. 
Increasing capital investment, also from abroad. Unemployment rate: 0.9% (1997).  
 
History and Patterns of drugs use 
Drugs appeared first in the period of student unrest at the end of the 1960s. During the 1970s 
and the 1980s drug use remained a marginal and hidden phenomenon. Drugs used were mostly 
pharmaceuticals. The typical drug of 1980s were homemade pervitin (a methamphetamine) and 
Braun (an opiate containing codeine). With the socio-political changes in 1989 the country started 
a difficult process transformation and an dramatic increase in drug consumption. Pharmaceuticals 
containing psychoactive substances (particularly opiates or stimulants) and volatile substances 
were most commonly used drugs In recent years the use of these pharmaceuticals has been 
rather stable, but the use of 'new' drugs has increased considerably, especially the recreational 
use of cannabis and hallucinogens among (outgoing) young people. Heroin entered the market in 
the 1990s and is mostly used intravenously. 
 
Drug interventions and policy 
In the past drug treatment was provided by psychiatric outpatient services specialised on the 
treatment of alcohol and drug use-related problems, and specialised departments of psychiatric 
and general hospitals. Since the beginning of the 1990s the health care system has been 
reformed, which included the privatisation of health care facilities and decentralisation of services. 
In the field of drug treatment and care the number of non-governmental organisations has grown. 
Among these there are new low-threshold centres that are more flexible of adopting less 
traditional approaches in treatment, rehabilitation, and counselling. Recent developments are 
syringe and needle exchange programmes, substitution therapy (though on a rather limited scale) 
and long-term treatment in therapeutic communities. 
With respect to intervention control priority is given to police intervention and prosecution. In 1994 
a new Penal Code has been introduced. Individual use and possession of drugs for personal use 
is not a criminal offence. Offenders of a drug laws can voluntary apply for treatment. The Anti-
drug Commission of the Municipality of Prague, formed by representatives from local authorities, 
the police and drug, health and social agencies, formulates priorities for drug policy in the city. 
One of the major policy goals is to create a balance between repressive and preventive 
measures. In the 1990s drug use, particularly regarding young people, has become a subject of 
public concern and debate.  
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PREVALENCE
Cannabis use general population school population Cannabis prevalence
Ever (LTP) 39.4% 1999
Recent (LYP) 6.3% 1996 34.1% 1999
Current (LMP) 20.2% 1999
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 533 1997
All treatment 1578 1996
first treatment Mean age 21.1 1997
first treatment % < 25 83.7% 1997
first treatment % females 42.6% 1997
Opiate substitution
First substitution
All substitution 25 1997
Mean age
% < 25
% females
Hospital episodes Hospital admissions
Psychiatric hospitals 983 1996
General hospitals
Non-fatal emergencies 38 1997
HEALTH
Injecting drug use
Estimated IDU prevalence 70.0% 1997
reference: all treatment
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 11 1997
Hepatitis C 43 1997
HIV 3 1997
Aids 0 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests  Convictions
Trafficking
Consumption
Total arrests 279 1997
Convictions for drug law offences
Total convictions 81 1997
DRUGS MARKET
Drug seizures Drug prices
Cannabis 32 1997
Heroin 14 1997
Cocaine 10 1997
Amphetamines 13 1997
Ecstasy
Indicator data and trends PRAGUE 
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SOFIA Context 
 
 
Population: 1.142.000 (1996) 
 
Geography 
Capital city of Bulgaria. National centre of economic activity. Socio-political changes at the 
beginning of the 1990s have put the economy in a crisis. Relatively high level of unemployment.  
 
History and Patterns of drugs use 
In the mid-1960s small groups influenced by youth subcultures in the Western world, started to 
use drugs, mainly opiates like morphine, codeine. Injecting was the common route of 
administration. A second wave of drug use appeared between the mid-1970s and the mid-1980s. 
This involved opiates, benzodiazepines, hallucinogenic medicines (antiparkinson medicines) and 
solvents. The third wave started in the late 1980s in a period of liberalisation and large transitions 
in society. From 1991-92 onwards the use of illicit drugs has been steadily increased. A new 
generation of heroin users appeared; most of them injected their drugs. There is no evidence for 
home production of heroin in Bulgaria. Volatile substance abuse decreased. Cocaine (sniffing) is 
possibly used by selected groups. Next to cannabis, new drugs like ecstasy gained popularity 
among young people. School survey data indicate that cannabis is the most common used drug 
among students aged 14-18 years. In 1995 the number of drug users in the city was estimated at 
10000-15000, from which approximately 4000-5000 probably are a regular user. Although 
injecting still is the main route of heroin administration, recently chasing the dragon has been 
observed among young heroin users and long-term users who switch because of physical 
problems with intravenous use. 
 
Drug interventions and policy 
Before 1993 all activities concerning drug problems were developed by different institutions more 
or less separately. In 1992-93 more integrated demand and supply reduction policies started. An 
important stage in this process was the establishment of the National Inter-ministerial Council to 
Combat Illicit Trafficking and Drug Misuse. Its main goal is to coordinate and consolidate the 
activities of all institutions engaged with drug problems. Today, the main treatment facility in Sofia 
is incorporated in the National Centre for Addictions (NCA). NCA has been the basis for the 
development of a number of inpatient and outpatient programmes, including a methadone 
maintenance programme and prevention projects schools. 
Under the Public Health Law the Ministry of Health controls the production, processing, storage, 
import, export and accountancy of psychotropic substances and their precursors. There is a fine 
for distributing opiate substances. At present it is considered to develop laws on compulsory 
treatment for convicted drug users.  
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 395
All treatment 974
first treatment Mean age 21.0
first treatment % < 25 85.8%
first treatment % females 19.2%
Opiate substitution
First substitution
All substitution 240
all treatment Mean age 27.2
all treatment % < 25 52.1%
all treatment % females 23.3%
Hospital episodes Non fatal emergencies
Psychiatric hospitals
General hospitals
Non-fatal emergencies 338 1997
HEALTH
Injecting drug use Drug related deaths
Estimated IDU prevalence 75.0% 1997
reference unknown
Mortality
Drug related deaths 20 1997
infectious diseases incidence in IDU % IDU infected
Hepatitis B 17.5% 1997
Hepatitis C 77.5% 1997
HIV 3.5% 1997
Aids
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by drug
Trafficking 244
Consumption
Total arrests 244
Convictions for drug law offences
Total convictions 70 1997
DRUGS MARKET
Drug seizures
Cannabis 7
Heroin 20
Cocaine 8
Amphetamines 1
Ecstasy
CAN
OTHER
Indicator data and trends SOFIA 
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STOCKHOLM Context 
 
 
Population: 718.000 (1996) 
 
No context information available. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment
All treatment 2375 1996
Mean age
first treatment % < 25 10.4% 1996
first treatment % females 28.0% 1996
HEALTH
Mortality Drug related deaths
Drug related deaths 61 1996
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 23 1996
Hepatitis C
HIV
Aids 19 1996
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 221 1996
Consumption 1127 1996
Total arrests 1348 1996
Convictions for drug law offences
Total convictions 1731 1996
DRUGS MARKET
Drug seizures Number of seizures
Cannabis 754 1996
Heroin 368 1996
Cocaine 21 1996
Amphetamines 1411 1996
Ecstasy
CAN
OTHER
1996
Indicator data and trends STOCKHOLM 
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ST.PETERSBURG Context 
 
 
Population: 4.716.000 (1998) 
 
Geography 
St.Petersburg is one of the biggest metropolitan areas of Europe, where 4.5% of urban 
population of Russia lives. Socio-demographic processes in St-Petersburg are similar to those, 
which are observed for Russia as a whole. Main demographic trends: population decrease, in 
particular in the younger age groups. St.Petersburg is an important industrial, commercial and 
transport centre. General economic situation is a bit better than compared to Moscow or other 
Russian cities. The official unemployment rate in 1997 was 9%. Due to its location the city is 
more open to influences from other countries, which affects the drug situation (diffusion of 
lifestyles, import and transit of drugs). 
 
History and Patterns of drugs use 
A sharp increase in the use of illicit drugs has been noted after the 1995 anti-alcohol campaign. 
Homemade opiates and cannabis are the prevailing drugs. In the late 1990s an aggressive 
spreading of heroin on the drug market is observed, replacing homemade opiates and combined 
with a sharp increase of drug injecting. The trend coincides with a decrease of both quality and 
prices of street heroin. Prevalence of drug use is thought to be higher than in other areas of 
Russia. The increase of drug addiction is reflecting the rapid social, economic and political 
changes in the last 15 years: split of society into poor and rich, increased crime, ideological 
vacuum in formation. 
 
Drug interventions and policy 
Treatment demand increases in particular related to heroin use. The city has 35 centres for 
inpatient and outpatient treatment. In recent years a large number of specialised social services 
emerged: centres for assistance to families, hotlines for teenagers, self-help groups. Beside the 
state of city-financed centres also commercial ones have appeared and drug treatment is also 
provided by private practioners. Their interventions are however not covered in official statistics.  
Local drug policies are in line with state policies and are coordinated by the Coordination Council 
on Counteracting Narcotics and Narcobusiness. 
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PREVALENCE
Problem drug use
Prevalence estimate 1974
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 2623
All treatment 6881
first treatment Mean age 23.0
first treatment % < 25 79.3%
first treatment % females 23.6%
Hospital episodes Hospital admissions Non fatal emergencies
Psychiatric hospitals 3810
General hospitals 261
Non-fatal emergencies 3342
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 93.0%
reference: all treatment
Mortality
Drug related deaths 86
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 520
Hepatitis C
HIV 1.3% 1996
Aids 7 1996
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 261 1997
Consumption 4303 1997
Total arrests 8744
Convictions for drug law offences
Total convictions 5285
DRUGS MARKET
Drug seizures Number of seizures Drug prices
Cannabis 2451
Heroin 3654
Cocaine 15
Amphetamines 48
Ecstasy
CAN
OTHER
Indicator data and trends ST.PETERSBURG 
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VARNA Context 
 
 
Population: 305.000 (1997) 
 
Geography 
Seaport on the Black Sea. Transport, industrial and tourist centre. Negative economic 
development in the early 1990s, recovering since 1997.  
 
History and Patterns of drugs use 
In the late 1960s drug use was concentrated in a small subgroup of users of opiates, 
tranquillisers and barbiturates. In the 1980s new patterns emerged of abuse of medicines in 
combination with alcohol and of solvents sniffing among children of 10-12 years. The situation 
really changed with the democratic development in the late 1980s and early 1990s when heroin 
appeared on the local market, followed by an increase in treatment demands, non-fatal 
emergencies and Hepatitis B cases. A group of a few hundred heroin users in the minority group 
of Gypsies constitute a specific local problem.  
Main drugs today are cannabis, heroin, medicines in combination with alcohol, cocaine and 
ecstasy. School survey data show that in 1997 cannabis is the most popular drug among pupils 
aged 15-18 years, followed by tranquillisers and barbiturates. Among heroin users injecting is the 
main route of heroin administration, though not so among heroin users from ethnic minorities 
(Arabs, Iranians, Gypsies). Cocaine use seems to be restricted among the ‘nouveau riche’.  
 
Drug interventions and policy 
Inpatient and outpatient units for medical treatment and psychotherapy of drug users are 
available since 1973. Intervention facilities have been extended since the early 1990s, including 
today school prevention projects and syringe exchange programme. 
Varna has a Permanent Commission on Drug Problems in which local authorities, specialised 
drug agencies, general health and social agencies, the police, the educational system and justice 
authorities participate. The focus of local policy is on prevention measures. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 39 1997
All treatment 75 1997
first treatment Mean age 21.7 1997
first treatment % < 25 79.0% 1997
first treatment % females 15.0% 1997
Hospital episodes Hospital admissions Non fatal emergencies
Psychiatric hospitals 48 1997
General hospitals 77 1997
Non-fatal emergencies 104 1997
HEALTH
Injecting drug use Prevalence of IDU Drug related deaths
Estimated IDU prevalence 68.0% 1997
reference: all treatment
Mortality
Drug related deaths 3 1997
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 5 1997
Hepatitis C
HIV
Aids 0 1997
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug  Convictions
Trafficking 6 1996
Consumption 2 1996
Total arrests 23 1997
Convictions for drug law offences
Total convictions 8 1997
DRUGS MARKET no (recent) data
CAN
OTHER
1997
Indicator data and trends VARNA 
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WARSAW Context 
 
 
Population: 1.629.000 (1996) 
 
Geography 
Capital city of Poland. National centre of trade, industry, culture and tourism and international 
transport junction on the East-West route. Unemployment rate: 2.8% (1997). Warsaw's current 
rate of economic growth is higher than the average for Poland as a whole. 
 
History and Patterns of drugs use 
Drug use was first observed in the late 1960s. The scene was at first dominated by home made 
opiates, volatile substances, sedatives and sleeping pills. This has changed in the 1990s when 
cannabis, amphetamines, hallucinogens and synthetic drugs became more common drugs, in 
particular among young people and often related to specific lifestyle subcultures. School survey 
data indicate that cannabis is the most common illicit drug used, followed by amphetamines and 
LSD. However, sedatives, tranquillisers and solvents are still more common than any illicit drugs 
other than cannabis. Problem drug use mainly regards heroin and other opiates. The main route 
of administration of opiates is injecting. Treatment demand data indicate that a new pattern of 
problem use has emerged related to amphetamines and cannabis.  
 
Drug interventions and policy 
Treatment and rehabilitation is provided by several specialised centres. Some experimental 
methadone programmes have been implemented in Warsaw, but methadone therapy is not yet 
regarded a routine treatment method. In order to ensure access of drug users to social 
assistance and support, a foundation has been established to improve cooperation between the 
city's social assistance centres and treatment services.  
In 1997 the police structure responsible for drug-related issues has been changed. The main 
focus is combating illegal drug production (poppy and hemp cultivation) and trafficking of drugs, 
and the prevention of production and trafficking of new substances like amphetamines and 
cannabis. The police are usually more tolerant towards individual users of kompot, who produce it 
for their own consumption or sell small amounts.  
The revised laws on drugs of 1997 include a legal basis for substitution treatment, control over 
precursors and extension of probation mechanism. The law of 1997 was preceded by several 
years of public debate, parallel to the resettling of the Polish drug scene in the 1990s. News 
media paid much attention at the problems related to transitions in the illegal drug market and the 
increase of use among young people. 
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PREVALENCE no (recent) data
TREATMENT
Treatment demand
First treatment 270 1996
All treatment 1023 1996
first treatment Mean age 24.0 1996
first treatment % < 25 71.5% 1996
first treatment % females 18.1% 1996
Hospital episodes Hospital admissions
Psychiatric hospitals 292 1996
General hospitals
Non-fatal emergencies
HEALTH
Mortality Drug related deaths
Drug related deaths
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B
Hepatitis C
HIV 20 1996
Aids 9 1996
DRUG LAW OFFENCES
Arrests for drug law offences Arrests  Convictions
Trafficking
Consumption
Total arrests 4600 1996
Convictions for drug law offences
Total convictions 33 1997
DRUGS MARKET
Drug seizures Number of seizures
Cannabis
Heroin
Cocaine
Amphetamines
Ecstasy
Indicator data and trends WARSAW 
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YAROSLAVL Context 
 
 
Population: 628.000 (1996) 
 
Geography 
Situated north east of Moscow in the Russian heartland. About 37% of the population is in the 
age group 15-39 years. Compact city with no suburban area. Main industries are oil refining and 
engine building. 
 
History and Patterns of drugs use 
Drug problems started in the early 1990s with homemade opiates and cannabis as the most 
popular drugs. Situation keeps worsening, but official figures are still quite low. Registered drug 
addicts increased from 29 in 1994 to 77 in 1996, among them no children and teenagers. Heroin 
and methadone abuse has been observed in recent years. Among youngsters ecstasy became 
widely spread. Based on treatment data the increase of drug abuse is coincides with the 
migration of refugees from southern regions of the former Soviet Union. Intravenous drug use is 
increasing. 
 
Drug interventions and policy 
Treatment demand increases, majority of treatment demands relate to opiate users. Treatment is 
provided by specialised psychiatric centres. Health indicators show increasing problems. Police 
interventions also increase. 
Drug policies are developed and implemented by a regional committee to combat drug use and 
illegal drug trafficking, based on a formal regional programme.  
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PREVALENCE no (recent) data
TREATMENT
Treatment demand First and all treatment Mean age and % < 25  % females
First treatment 160
All treatment 271
first treatment Mean age 24.0
first treatment % < 25 81.8%
first treatment % females 17.5%
Hospital episodes Hospital admissions Non fatal emergencies
Psychiatric hospitals 231
General hospitals
Non-fatal emergencies 229
HEALTH
Mortality Drug related deaths
Drug related deaths 17
infectious diseases incidence in IDU % IDU infected Incidence in IDU
Hepatitis B 42
Hepatitis C
HIV
Aids 5
DRUG LAW OFFENCES
Arrests for drug law offences Arrests by offence Arrests by drug
Trafficking 158
Consumption 583
Total arrests 741
Convictions for drug law offences
Total convictions 292
DRUGS MARKET
Drug seizures Number of seizures Drug prices
Cannabis 48
Heroin 135
Cocaine 3
Amphetamines 7 1997
Ecstasy
CAN
OTHER
1997
Indicator data and trends YAROSLAVL 
 
 
 90 
 91
   4 
EUROPEAN 
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 92 
 93
4.1 
INDICATOR TRENDS 
  
 
 
ACCOUNT OF DATA PRESENTATION 
In this section we present trends in individual indicators across Europe. As before, indicators are 
grouped along the categories of prevalence, treatment, health, drug law offences and drugs 
market. Trend information is presented as far as predefined selection criteria are met in two 
different formats. 
• Tables of recent indicator values and/or trends per city 
 The tables have been constructed if we have recent figures of at least 10 cities. As in the 
case of the city profiles, ‘recent’ means a figure of 1996 or later. In general figures refer 
to 1998, if not the appropriate year is listed in italics next to a figure. Whenever applicable 
figures are presented as RATES per 100.000 of the city’s population. 
  Trends refer to the period 1991-1998. Trend orientation is presented by the following 
symbols: 
 UP 
 DOWN 
 STABLE 
  Trends have been assessed as by calculating the slope of a linear regression line to 
identify trend orientation and Pearson’s product moment correlation coefficient to identify 
trend significance. Although a linear model not always provides a best fit for actual trend 
developments, it is assumed to be appropriate for the purpose of rapid trend assessment. 
Trends are labelled UP or DOWN when Pearson’s R2 > 0.5, otherwise a trend is labelled 
as STABLE. No trends are indicated if we have less than 3 data for the reporting period. 
• Thematic maps showing relative magnitude of indicators and trends per city  
Maps present indicator data as circles or pie charts on each city. The size of circles is 
relative to the indicator figure or, whenever applicable, the rate per 100.000. For practical 
reasons figures and rates refer to AVERAGE figures and rates for the years 1996-1998. 
Slices of pie charts are relative to the percentage of a subcategory of an indicator. 
Colours of circles or slices indicate trend orientation, whereby the labelling as UP (red), 
DOWN (blue) or STABLE (yellow) follows the rules described above. If no trend can be 
assessed because we have less than 3 figures, circles and slices are given a neutral 
grey colour. 
Maps are only included for a selection of indicators. 
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PREVALENCE 
 
Last month prevalence in % 
among school population trend 
Amsterdam 23.0% 1997 4  
Paris 23.0%  1  
Madrid 20.7% 1997 1  
Prague 20.2%  1  
Gdansk 8.7% 1997 3  
Bratislava 8.5%  2  
Athens 8.2%  2  
Lisbon 6.3% 1998 3  
Moscow 3.5% 1999 1  
Malta 2.7%  2  
 
 
TREATMENT 
  
All treatment demand 
per 100.000 of population trend 
% first 
treated 
Perm 1548  4  10% 
Krasnodar 749  5  35% 
Amsterdam 426  8  7% 
Novosibirsk 409  5  18% 
Dublin 366  8  26% 
Kaliningrad 360  3  13% 
Stockholm 338 1996 6   
Copenhagen 336 1997 4  15% 
Hamburg 295 1996 4  56% 
Liege 270 1996 2  67% 
Moscow 236  5  52% 
Budapest 234  5  65% 
Kemerovo 234  4  72% 
Bratislava 229  4  35% 
Barcelona 220 1997 7  39% 
Malta 211 1999 6  17% 
Madrid 193  2   
Brussels 190 1997 1   
Gdansk 175  5  28% 
Orenburg 168  5  69% 
Geneva 167 1997 7  24% 
St.Petersburg 145  5  38% 
Jekaterinburg 131  1  46% 
Prague 130 1996 4  34% 
Paris 124 1997 4  96% 
Ljubljana 84 1997 7  54% 
Sofia 83  4  41% 
Warsaw 63 1996 2  26% 
Debrecen 51 1997 1  77% 
Yaroslavl 43  5  59% 
Varna 23 1997 4  52% 
Athens 22  5  44% 
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First treatment demand  
per 100.000 of population trend 
 mean 
age trend 
 % 
females  trend 
Krasnodar 259  5   22.2   12%  
Liege 182 1996 1   24.5     
Kemerovo 167  4   20.7   23%  
Hamburg 165 1996 4      32%  
Budapest 153  5      36%  
Perm 152  4      11%  
Moscow 123  5      19%  
Paris 119  5   33.0   27%  
Orenburg 117  5   22.2   6%  
Dublin 95  8   21.7   32%  
Barcelona 86 1997 7   28.0   22%  
Bratislava 81  4   21.9   31%  
Novosibirsk 73  5      15%  
Charleroi 63  1   24.7   15%  
Helsinki 62 1996 6        
Jekaterinburg 61  1        
St.Petersburg 55  5   23.0   24%  
Copenhagen 51 1997 4   31.7   24%  
Gdansk 48  5   18.7   26%  
Ljubljana 45 1997 7   23.2   24%  
Kaliningrad 45  3   25.7   21%  
Prague 44 1997 5   21.1   43%  
Geneva 41 1997 7   27.7   15%  
Debrecen 39 1997 1      18%  
Malta 35 1999 6   24.7   16%  
Sofia 34  4   21.0   19%  
Amsterdam 28  8   34.2   28%  
Yaroslavl 26  5   24.0   18%  
Warsaw 17 1996 2   24.0   18%  
Varna 12 1997 4   21.7   15%  
Albania 10 1997 3      8%  
Athens 10  5   34.1   19%  
 
 
Admissions to general hospitals 
per 100.000 of population trend 
Perm 167 1997 3  
Hamburg 29 1997 5  
Novosibirsk 27  4  
Varna 24 1997 4  
Krasnodar 22  5  
Orenburg 10  5  
St.Petersburg 5  5  
Helsinki 5  7  
Ljubljana 0 1996 6  
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Admissions to psychiatric hospitals 
per 100.000 of population trend 
Perm 339  4  
Liege 267 1996 1  
Moscow 117  5  
Krasnodar 105  5  
Kemerovo 82  4  
Prague 81 1996 2  
St.Petersburg 80  5  
Hamburg 78 1997 5  
Helsinki 67  7  
Novosibirsk 50  5  
Yaroslavl 37  5  
Orenburg 25  5  
Warsaw 18 1996 6  
Varna 15 1997 4  
Ljubljana 14 1996 6  
Kaliningrad 10  2  
 
Drug related non-fatal emergencies 
per 100.000 of population trend 
Perm 479  4  
Oslo 260 1997 1  
Barcelona 192 1997 7  
Orenburg 117  5  
Kemerovo 101  1  
Hamburg 88 1996 4  
Amsterdam 84  8  
Budapest 83  3  
Gdansk 79  8  
St.Petersburg 70  5  
Krasnodar 53  5  
Liege 40 1996 1  
Yaroslavl 37  5  
Malta 35 1999 3  
Jekaterinburg 35  1  
Varna 33 1997 4  
Ljubljana 31 1997 4  
Novosibirsk 30  3  
Sofia 29 1997 4  
Madrid 25  2  
Kaliningrad 7  3  
Charleroi 4  1  
Prague 3 1997 2  
 All Treatment Demand 
 Size of circles is relative to RATE of ALL TREATMENT DEMAND per 100.000 of population  
Colours of circles indicate TREND of ALL TREATMENT DEMAND: 
  UP   DOWN   STABLE   no trend available 97
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% First treated of all treatment demand 
 
Size of circles is relative to RATE of ALL TREATMENT DEMAND per 100.000 of population  
Size of slices is relative to % FIRST TREATED of all treatment demand 
Colours of slices indicate TREND of FIRST TREATMENT DEMAND: 
 UP   DOWN  STABLE  no trend available
 Mean age first treatment demand 
 
 Size of circles is relative to MEAN AGE in FIRST TREATMENT DEMAND  
Colours of circles indicate TREND of MEAN AGE in first treatment demand: 
  UP   DOWN   STABLE   no trend available 99
 100 
% Females in first treatment demand 
 
Size of circles is relative to % FEMALES in FIRST TREATMENT DEMAND  
Colours of circles indicate TREND of % FEMALES in first treatment demand 
  UP   DOWN   STABLE   no trend available 
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Drug related non-fatal emergencies 
 
Size of circles is relative to RATE of NON-FATAL EMERGENCIES per 100.000 of population  
Colours of circles indicate TREND in NON-FATAL EMERGENCIES 
  UP   DOWN   STABLE   no trend available 
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HEALTH 
 
Drug related deaths 
per 100.000 of population trend 
 N of 
cases 
Oslo 19.6 1997 6   95 
Copenhagen 15.5 1997 7   73 
Kemerovo 14.9  4   76 
Dublin 14.8  4   136 
Lisbon 11.5  7   212 
Jekaterinburg 10.7  1   141 
Budapest 10.6 1997 3   207 
Stockholm 8.7 1996 6   61 
Orenburg 8.4  5   45 
Geneva 7.9 1996 6   31 
Athens 7.8  8   239 
Barcelona 7.7 1997 7   122 
Hamburg 7.5 1997 5   127 
Perm 7.0  5   24 
Gdansk 6.1  8   46 
Madrid 5.9  2   170 
Novosibirsk 5.5  4   77 
Charleroi 5.4  1   11 
Krasnodar 4.6  5   35 
Bratislava 4.0  1   18 
Amsterdam 3.5  8   25 
Moscow 3.3  3   285 
Ljubljana 3.1 1997 7   10 
Kaliningrad 2.8  3   12 
Yaroslavl 2.7  4   17 
Helsinki 2.6  8   14 
Malta 2.1 1999 3   8 
St.Petersburg 1.8  5   86 
Paris 1.8  7   38 
Sofia 1.7 1997 3   20 
Varna 0.9 1997 4   3 
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Estimated % injectors 
among drug users trend  reference population 
Gdansk 96%  5   unknown 
St.Petersburg 93%  5   all treatment demand 
Hamburg 90% 1996 2   all treatment demand 
Kaliningrad 87% 1997 2   all treatment demand 
Krasnodar 85%  4   first treatment demand 
Novosibirsk 83%  3   all treatment demand 
Orenburg 83%  5   all treatment demand 
Bratislava 78%  1   unknown 
Sofia 75% 1997 1   unknown 
Prague 70% 1997 1   all treatment demand 
Varna 68% 1997 4   all treatment demand 
Charleroi 56%  1   unknown 
Athens 52% 1997 4   first treatment demand 
Barcelona 41% 1997 7   all treatment demand 
Dublin 35% 1996 1   all treatment demand 
Geneva 34% 1997 7   first treatment demand 
Albania 34% 1997 3   first treatment demand 
Budapest 26% 1997 3   all treatment demand 
Madrid 22%  2   unknown 
Amsterdam 21%  1   unknown 
Paris 18%  3   all treatment demand 
Copenhagen 15% 1997 4   all treatment demand 
Malta 6% 1997 1   first treatment demand 
 
 
Incidence of Hepatitis B among IDU 
per 100.000 of population  trend  
N of 
cases 
Perm 130.7 1997 3   450 
Kemerovo 38.6  3   197 
Novosibirsk 23.4  4   327 
Orenburg 18.7  5   100 
St.Petersburg 10.9  5   520 
Yaroslavl 6.7  4   42 
Krasnodar 6.7  5   51 
Kaliningrad 6.4  3   27 
Oslo 5.8 1997 6   28 
Gdansk 4.1  8   31 
Stockholm 3.3 1996 6   23 
Varna 1.6 1997 4   5 
Bratislava 1.3 1997 3   6 
Copenhagen 1.1 1997 1   5 
Prague 0.9 1997 2   11 
Malta 0.5 1997 1   2 
Geneva 0.3 1997 7   1 
Ljubljana 0.0 1996 6   0 
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Incidence of AIDS among IDU 
per 100.000 of population  trend  
N of 
cases 
Lisbon 12.4  6   228 
Barcelona 10.3 1997 7   162 
Perm 6.1  2   21 
Geneva 5.6 1997 7   22 
Krasnodar 4.0  5   31 
Paris 3.6 1997 7   77 
Stockholm 2.7 1996 6   19 
Amsterdam 1.4  8   10 
Kemerovo 1.4  3   7 
Gdansk 1.3  8   10 
Novosibirsk 1.3  3   18 
Copenhagen 1.1 1997 7   5 
Oslo 0.8 1997 6   4 
Yaroslavl 0.8  2   5 
Ljubljana 0.6 1997 7   2 
Warsaw 0.6 1996 6   9 
Hamburg 0.5 1996 4   9 
Kaliningrad 0.5  3   2 
Moscow 0.2  1   17 
St.Petersburg 0.1 1996 2   7 
Athens 0.1  2   3 
Bratislava 0.0 1997 3   0 
Malta 0.0 1997 1   0 
Prague 0.0 1997 4   0 
Varna 0.0 1997 4   0 
 Drug related deaths 
 Size of circles is relative to RATE of DRUG RELATED DEATHS per 100.000 of population  
Colours of circles indicate TREND in DRUG RELATED DEATHS 
  UP   DOWN   STABLE   no trend available 105
 106 
Drug related incidence of AIDS 
 
 
 Size of circles is relative to RATE of ALL AIDS INCIDENCE per 100.000 of population  
Size of slices is relative to % IDU among all AIDS incidence cases 
Colours of slices indicate TREND of AIDS INCIDENCE AMONG INJECTING DRUG USERS
 UP   DOWN  STABLE  no trend available
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DRUG LAW OFFENCES 
 
 Arrests 
for drug 
use 
 Arrests 
related to 
cannabis 
Arrests for drug law offences 
per 100.000 of population trend 
 trend  trend 
Copenhagen 1247 1997 7      
Perm 883  1      
Hamburg 780 1997 5      
Brussels 653 1997 1      
Charleroi 583  1      
Jekaterinburg 481  1      
Geneva 464 1996 4      
Amsterdam 391  8      
Helsinki 365  8      
Liege 361 1996 4      
Novosibirsk 351  4      
Dublin 321  7      
Warsaw 281 1996 5      
Kaliningrad 263  3      
Krasnodar 235  5      
Kemerovo 223 1997 3      
Stockholm 192 1996 5      
St.Petersburg 184  5      
Paris 176  8      
Athens 149 1997 7      
Orenburg 147  4      
Malta 122 1999 3      
Yaroslavl 118  5      
Lisbon 114  8      
Bratislava 110 1997 4      
Moscow 95  4      
Gdansk 25  8      
Prague 23 1997 6      
Sofia 21  1      
Budapest 15 1997 7      
Varna 7 1997 4      
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Convictions for drug law offences 
per 100.000 of population trend 
Perm 557  4  
Oslo 431 1997 1  
Stockholm 247 1996 6  
Novosibirsk 245  5  
Krasnodar 235  5  
Amsterdam 124 1996 6  
Orenburg 119  5  
Kaliningrad 119  3  
Jekaterinburg 117  1  
St.Petersburg 111  5  
Bratislava 111  6  
Kemerovo 108 1997 3  
Geneva 100 1996 6  
Moscow 89  1  
Hamburg 80 1996 5  
Paris 76  8  
Lisbon 59  8  
Yaroslavl 47  2  
Gdansk 8  8  
Prague 7 1997 6  
Sofia 6 1997 1  
Budapest 3  6  
Varna 3 1997 4  
Warsaw 2 1997 7  
 Total arrests for drug law offences 
 Size of circles is relative to RATE of ARRESTS for DRUG LAW OFFENCES per 100.000 of population  
Colours of circles indicate TREND in ARREST for DRUG LAW OFFENCES 
  UP   DOWN   STABLE   no trend available 109
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Arrests for drug law offences related to cannabis 
 
Size of circles is relative to RATE of ARRESTS for DRUG LAW OFFENCES per 100.000 of population  
Size of slices is relative to % CANNABIS RELATED among all arrests for drug law offences 
Colours of slices indicate TREND in CANNABIS RELATED ARRESTS: 
 UP   DOWN  STABLE  no trend available
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DRUGS MARKET 
 
 
 
 
 Trends in numbers of drug 
seizures 
Trends in amounts of drugs 
seized 
  Cannabis Heroin Cocaine Amphet.  Cannabis Heroin Cocaine Amphet. 
Albania          
Amsterdam          
Budapest          
Dublin          
Gdansk          
Geneva          
Hamburg          
Kaliningrad          
Lisbon          
Malta          
Moscow          
Novosibirsk          
Orenburg          
Oslo          
Paris          
St.Petersburg          
Stockholm          
Yaroslavl          
 
Purity of heroin at street level 
 trend 
Prague 70% 1997 1  
Madrid 50%  1  
Oslo 45% 1997 1  
Amsterdam 40% 1999 4  
Gdansk 38%  8  
Dublin 36%  8  
St.Petersburg 35%  1  
Budapest 30%  4  
Bratislava 18% 1997 1  
Athens 15% 1997 3  
 
 
 
 
Trends in prices of drugs at 
street level 
 Cannabis Heroin Cocaine Amphet. 
Amsterdam     
Dublin     
Gdansk     
Kaliningrad     
Kemerovo     
Lisbon     
Novosibirsk     
Orenburg     
Prague     
St.Petersburg     
Yaroslavl     
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Numbers of drug seizures by type of drug 
 Size of circles is relative to total NUMBER of DRUG SEIZURES  
Size of slices is relative to % of SPECIFIED DRUGS among all seizures: 
  CANNABIS   HEROIN   COCAINE   AMPHETAMINES 
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Drug seizures by type of drug 
 
 
Size of slices is relative to % of DRUGS among ALL SEIZURES: 
  CANNABIS   HEROIN   COCAINE   AMPHETAMINES 
NB. All seizures = 100% for each city 
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4.2 
AGGREGATE TRENDS 
(EAST-WEST COMPARISONS) 
  
 
 
ACCOUNT OF DATA PRESENTATION 
The previous section already shows that indicator trends of most Eastern European cities differ 
from those in Western Europe. Such differences can be more easily inspected by aggregating  
data of individual cities. In this section we compare aggregate trends between Eastern and 
Western European cities over the period 1991-1998, but the approach could make sense for 
other groupings of cities as well. 
The comparison is based on simple AVERAGES of indicator values across Eastern and Western 
European cities and presented in two formats. 
• Summary table of recent average indicator values and trends 
• Graphs showing developments of average indicators values  
Whenever applicable we have taken the RATES per 100.000 of population to calculate the 
averages. The table gives the most recent figure available. As before the cut-off point for ‘recent’ 
is set at 1996, so values prior to that year are not presented. In general the average figures refer 
to 1998, if not the appropriate year is listed in italics next to a figure.  
Average indicator values in each of the two clusters of cities are only calculated if we have for 
any year indicator data of at least 4 cities. The summary table lists the number of cities on which 
the average figure is calculated.  
Trends refer to the developments of the average figures in each cluster in the period 1991-1998. 
Trends have been assessed and labelled as described above in section 4.1. No trends are 
assessed if we have less than 3 figures for the reporting period for either Eastern or Western 
Europe.  
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SUMMARY OF TRENDS 
 
 Trend orientation  
 UP 
 DOWN 
 STABLE 
 
 EASTERN EUROPE WESTERN EUROPE 
 
value year 
no. of 
cities in 
average 
trend value year 
no. of 
cities in 
average 
trend 
TREATMENT 
         
First treatment demand   100  14  69  7  
All treatment demand  339  14  684  6  
Mean age (first treatment)   22.4  7  27.9  5  
% < 25 yrs (first treatment)   60.8%  10  47.5%  5  
% females (first treatment)   20.7%  12  21.2%  5  
Admissions psychiatric hospitals  94  9      
Admissions general hospitals  16  4      
Non-fatal emergencies  99  11  36  4  
HEALTH 
         
% estimate IDU prevalence   86.4%  6  29.2%  4  
Drug related deaths  6  12  6  9  
Hepatitis B incidence in IDU  14  8  2 1997 4  
AIDS incidence in IDU  2  8  3 1997 8  
DRUG LAW OFFENCES 
         
Arrests for traffick offences  74  9  98  7  
Arrests for drug use offences  173  6  172  6  
Arrests for any drug law offence  255  11  296  7  
Cannabis related arrests  34  6  107  4  
Convictions drug law offences  147  12  116 1996 6  
DRUGS MARKET 
         
Cannabis seizures  36  9  125  5  
Heroin seizures  38  9  37  5  
Cocaine seizures  1  8  15  5  
Amphetamines seizures  6  8  19  4  
Total drug seizures  97  9  204  5  
 
NB.: Average indicator values are RATES per 100.000 of population except those marked with  
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5.1 
ANALYSIS  
(RELATIONS BETWEEN INDICATORS) 
 
 
 
METHODS OF ANALYSIS 
    
The data collection of the Multicity network has been used in the past almost exclusively for 
descriptive purposes. Sections 3 and 4 of this report follow this trend. The descriptions of data 
and trends not only reveal substantial differences between European cities but also suggest 
many parallel trend developments in individual indicators. 
Previous reports of the Epidemiology Group have been largely restricted to interpretations of 
trends and comparisons of cities on a face-value basis. From a scientific point of view this is not 
very satisfying and with the growing number of cities in the network the approach becomes 
almost an impossible task too. In the framework of the 3rd Multicity Study we therefore attempt to 
a statistical analysis of European patterns in drug problems by taking the Multicity data collection 
as a convenient sample of cities to assess interrelations between indicators and to classify cities 
by common patterns of indicator trends  
The analysis has been carried out on the database constructed after the collection of 1997 data. 
This not only implies that the more recent data of 1998 are not included, but also that corrections 
on and additions to previous data, which have been delivered by some cities together with the 
1998 city data are not accounted for. Moreover, the analysis has been carried out on absolute 
figures of indicator data, not on figures standardised to rates per number of population.  
The analysis is primarily intended as an example exercise in exploration of patterns, illustrating 
the analytical potential of the Multicity database. For this reason we have not repeated the 
exercise on the updated database.    
The dataset 1991-1997 consists of 146 variables, covering 34 cities. However, the majority of 
these variables could not be included in the process of statistical analyses because of the large 
number of missing values. Moreover, eight cities had to be excluded completely from the analysis 
because their very high number of missing values. For the analysis we could select 32 variables 
of 26 cities (12 in Western and 14 in Eastern Europe) for 7 years (1991-1997), which means that 
we have for each variable a maximum of 26 x 7 = 182 cases. Not one variable however provides 
more than 75% valid cases and only 10 variables have more than 50% valid cases. 
In order to improve the potential for analysis, some 200 missing values in time series of variables 
have been imputed by calculated values if we had at least data for five years and these data 
showed a clear up- or downward trend. In such cases missing data have been replaced by the 
average of the known data from the preceding and following year or by the average of the known 
data of two preceding or following years. The procedure increased the average number of valid 
cases up to 43%. Even with this replacement of missing values, the dataset still looks like a 
Swiss cheese, or the negative image of a Swiss cheese, depending on one’s optimism. 
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Nevertheless, the remaining variables are nicely distributed over the key areas of indicator data 
of the Multicity network. Though we cannot include the key area of drug prevalence, the available 
data should allow a reasonable impression of the drug situation in the network.  
Relations between indicators 
Relations between different indicators have been explored by calculating correlations based on 
Pearson’s r. This might not be the most powerful statistical technique, but it is a common method 
for a first exploration of interrelations between data. Besides, the quality of the Multicity database 
at present does not justify higher levels of analysis. 
Indicators have been grouped into the categories of treatment (including characteristics of the 
treated population), health, drug law offences and drugs market. Pearson’s r has been calculated 
within indicator groups (intra-group correlations) and between groups (inter-group correlations).  
Pearson’s r correlation matrices are commonly used to develop hypotheses about the nature of 
interrelations between data. As we intend our exercises to be examples to encourage others to 
continue on more in-depth analysis, we include the results of the correlation analysis in this 
report. The figures presented in this report are reduced to those variables that show at least one 
significant correlation with another variable. 
The analysis has also been carried out for Eastern and Western European cities separately, 
which reveals that several relations only exist in one of these regions. In the presentation of 
results we only give an overview of the most explicit differences in interrelations. 
Classification of cities 
The differences between Eastern and Western Europe with regard to average indicator values, 
trend developments and the strength of relations between indicators, suggest that this regional 
aspect might be an important factor to explain differences in local drug use situations.  
Based on literature we also expect that city size could be an important discriminating factor. For 
this reason we added city size to our explorations of the Multicity dataset, whereby we reduced 
this aspect to an arbitrary simple dichotomy of 14 cities above and 12 below 1 million inhabitants. 
We tested both dichotomies in an analysis of variance and a multiple classification analysis, both 
for the whole time span 1991-1997, as well as for the individual years 1996 and 1997 to check 
the stability of the identified differences. The results are presented in table format. The Eta2 
values of the multiple classification analysis indicate the percentage of variance in the indicator 
explained by either the East-West or the City Size factor.  
For the orientation of the differences on each variable in the East-West comparison we refer to 
the tables in Section 4.2. It should be noted however that these tables refer to 1998 data, which 
have not been included in the tests, and give in most cases averages of variables standardised to 
rates per 100.000, whereas the tests have been conducted on the absolute indicator values. 
Information on the orientation of differences in the city size comparison is not provided in this 
report. 
  
 
RELATIONS WITHIN INDICATOR CATEGORIES 
    
Treatment 
All treatment demand correlates positively with first treatment demand. When more people enter 
treatment, the total number of people in treatment increases. This might not surprise at first sight, 
but actually also implies that inflow exceeds outflow. Both first and all treatment demand correlate 
positively with heroin users in treatment, which reflects the main orientation of most treatment 
centres. 
Correlation between admissions to psychiatric hospitals and treatment demand might be partially 
caused by overlap in data collection when psychiatric hospitals include drug treatment units. 
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Health 
As could be expected incidence of Hepatitis B and drug related deaths correlate with injecting 
drug use as a major health risk factor. The absence of a relationship between injecting and drug 
related Aids incidence might be due to the relative recent emergence of intravenous drug use in 
most cities compared to the slow rate of sero-conversion of HIV into Aids. At present we do not 
have information on HIV incidence as the Multicity network only collects these data since 1997.  
Drug law offences 
It might not surprise that arrests and convictions are interrelated. Both apparently measure law 
enforcement in more or less the same way. Although not shown in the correlation matrices below, 
we also found that convictions for drug law offences go parallel to the total number of convictions 
for any crime, which indicates that the workload of the courts depends highly on the amount of 
drug law offences. 
Market indicators  
Increasing seizures of one drug match increasing seizures of another. This could suggest that in 
most cities drugs markets are not separated, i.e. traffickers deal in all drugs, but it could also 
indicate that active law enforcement does not discriminate between different drugs. 
 
 
RELATIONS BETWEEN INDICATOR CATEGORIES 
 
Treatment and health 
There are strong relations between treatment and health indicators related to (consequences) of 
risk behaviour. This might be obvious by the choice of health indicators and the main orientation 
of treatment towards injecting heroin use. On the other hand, we have to realise that most health 
indicator data originate from treatment settings (e.g. incidences of Hepatitis B and Aids refer to 
people in treatment), so the indicators might be interdependent. We also find several negative 
correlations between treatment and health indicators. Their interpretation might require more 
detailed data about drug use patterns and other characteristics of the treated population. 
Treatment and drug law offences  
Trends in the number of arrests for trafficking and convictions for drug law offences run parallel to 
trends in the number of clients in first treatment. Treatment and drug law offences both seem to   
measure the size of the drug problem independently. There might be interdependence as well, 
e.g. if heroin users are a special target group for law enforcement and if arrested drug users 
choose treatment to avoid imprisonment. The relation then suggests that law enforcement is an 
important catchment system for treatment.   
Treatment and drugs market 
Both seizures of heroin and cocaine correlate with treatment indicators. As market indicators the 
numbers of drug seizures might indicate either a growing market or a (temporary) scarcity of 
substances on the market. In both cases the drugs market has an effect on treatment demand. 
Health, drug law offences and drugs market 
The correlations between health, drug law offences and drugs market indicators point at the 
impact of legal control on the health situation of drug users. Our findings confirm the relation 
between drug deaths and seizures, which has been previously explored in the Multicity network 
by Lenke and Olsson. 
Drug law offences and drugs market 
Finally, drug law offences and market indicators are highly interrelated, which could be expected, 
as by nature most drug law offences will imply some confiscation of the drugs involved. 
 
Our findings suggest that all groups of indicators measure the magnitude of the drug problem, in 
particular with regard to heroin use and injecting drug use. However, as we already remarked 
above, interdependence between indicators and categories cannot be excluded. 
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TREATMENT First treatment
All 
treatment
Mean age 
(FTD)
% females 
(FTD)
% < 25 yrs 
(FTD)
% Cann. 
users 
(FTD)
Heroin 
users 
(FTD)
% heroin 
users 
(FTD)
Admiss. 
psychiatr. 
hospitals
Admiss. 
general 
hospitals
Non-fatal 
emergen-
cies
First treatment demand (FTD)
All treatment demand (ATD) 0.61
Mean age (first treatment)
% females (first treatment) -0.25
% < 25 yrs (first treatment) -0.59
% cannabis users (first treatment) -0.33 -0.34 -0.37
Heroin users (first treatment) 0.71 0.58 -0.39
% heroin users (first treatment) -0.40 0.27
Admissions to psychiatric hospitals 0.87 0.80 0.30 -0.42
Admissions to general hospitals 0.44 0.46 0.92
Non-fatal emergencies 0.45 0.29 -0.35 -0.39 0.85 0.66 0.48
HEALTH Hep. B (IDU) AIDS (IDU)
Drug 
deaths
% IDU 
(FTD)
% IDU 
(ATD)
Incidence of Hepatitis B in IDU
Incidence of AIDS in IDU
Drug related deaths 0.37
% IDU (first treatment) 0.64
% IDU (all treatment) 0.67 0.43 0.85
DRUG LAW OFFENCES Traffick arrests
Total DLO 
arrests
Total DLO 
convict.
Prison 
sentence
Arrests for drug trafficking offences
Arrests any drug law offences (DLO) 0.76
Convictions drug law offences 0.30 0.87
Prison sentences for DLO 0.48
DRUGS MARKET Cannabis seizures
Heroin 
seizures
Cocaine 
seizures
Amphet. 
seizures
Cannabis seizures
Heroin seizures 0.42
Cocaine seizures 0.88 0.44
Amphetamine seizures 0.68 0.30 0.55
TREATMENT / HEALTH Hep. B (IDU) AIDS (IDU)
Drug 
deaths
% IDU 
(FTD)
% IDU 
(ATD)
First treatment demand (FTD) 0.40 0.56 0.52 0.37
All treatment demand (ATD) 0.51 0.22 0.34 0.52 0.39
Mean age (first treatment) -0.42
% females (first treatment) -0.30
% < 25 yrs (first treatment) -0.34 0.51 0.42
% cannabis users (first treatment) -0.58 -0.41 -0.36
Heroin users (first treatment) 0.60 0.61
% heroin users (first treatment) -0.74 -0.46 -0.30 -0.31
Admissions to psychiatric hospitals 0.66 0.63 0.75 0.69
Admissions to general hospitals 0.26
Non-fatal emergencies 0.35 0.50 0.87
INTRA-GROUP CORRELATIONS 
0.61 positive significant correlation 
-0.25 negative significant correlation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTER-GROUP CORRELATIONS 
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TREATMENT / DRUG LAW 
OFFENCES
Traffick 
arrests
Total DLO 
arrests
Total DLO 
convict.
Prison 
sentence
First treatment demand (FTD) 0.59 0.44 0.36
All treatment demand (ATD) 0.47
Mean age (first treatment) 0.41 0.47
% females (first treatment) 0.38
% < 25 yrs (first treatment) -0.43 -0.33
% cannabis users (first treatment)
Heroin users (first treatment) 0.62 0.69
% heroin users (first treatment) -0.34
Admissions to psychiatric hospitals 0.59
Admissions to general hospitals 0.55 0.28 0.43
Non-fatal emergencies 0.53 0.41
TREATMENT / DRUGS 
MARKET
Cannabis 
seizures
Heroin 
seizures
Cocaine 
seizures
Amphet. 
seizures
First treatment demand (FTD) 0.50
All treatment demand (ATD)
Mean age (first treatment) 0.55
% females (first treatment) 0.34
% < 25 yrs (first treatment) -0.47 -0.57
% cannabis users (first treatment) 0.82 0.94
Heroin users (first treatment) 0.68 0.81
% heroin users (first treatment) 0.45
Admissions to psychiatric hospitals 0.42 0.90
Admissions to general hospitals 0.59 0.57
Non-fatal emergencies
HEALTH / DRUG LAW 
OFFENCES
Traffick 
arrests
Total DLO 
arrests
Total DLO 
convict.
Prison 
sentence
Incidence of Hepatitis B in IDU 0.43 -0.44
Incidence of AIDS in IDU
Drug related deaths 0.69 0.68 0.41 0.39
% IDU (first treatment) 0.57 0.46 0.52
% IDU (all treatment) 0.60 0.42
HEALTH / DRUGS MARKET Cannabis seizures
Heroin 
seizures
Cocaine 
seizures
Amphet. 
seizures
Incidence of Hepatitis B in IDU -0.38
Incidence of AIDS in IDU
Drug related deaths 0.49 0.50 0.25
% IDU (first treatment)
% IDU (all treatment)
DRUG LAW OFFENCES / 
DRUGS MARKET
Cannabis 
seizures
Heroin 
seizures
Cocaine 
seizures
Amphet. 
seizures
Arrests for drug trafficking offences 0.55 0.45 0.40
Arrests any drug law offences (DLO) 0.95 0.65 0.79 0.47
Convictions drug law offences 0.96 0.58 0.80 0.93
Prison sentences for DLO 0.98 0.43 0.87 0.99
Convictions drug offences 0.92 0.47 0.78 0.76
DLO prison sentences 0.36 0.50 0.34
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EAST-WEST DIFFERENCES 
    
The relations between individual indicators have also been explored for Eastern and Western 
European cities separately. Although most relations can be found both in the West and in the 
East, several relationships only exist in one of the regions and often there are clear differences in 
the strength of the relations. We present the results in a table listing those relations, which only 
exist in either Western Europe or Eastern Europe or which show an opposite orientation of the 
relation in these regions. The table only lists significant correlations with an r-value > 0.70. 
The East-West distinction has also been tested in a multiple classification analysis. The results 
are presented in a table of Eta2 values of each indicator for the whole time span 1991-1997. Any 
significant Eta2 > 0.10 means that the East-West factor adds to the explanation of the variance in 
the indicator. Significant Eta2 values for the single years 1996 and 1997 indicate consistency. 
The table also presents the significance of interaction effects between the East-West and the City 
Size factor. 
  
Eastern Europe 
In contrast to Western Europe increase in all treatment does not correlate with increase in the 
proportion of heroin users in first treatment. This might be an effect of the recent switch from the 
traditional use of homemade opiates to heroin. Eastern European cities show strong relations 
between treatment indicators at one hand and drug law offences and drugs market indicators at 
the other. The strong Western European relations between the proportions of heroin and injecting 
users in first treatment with law enforcement and market indicators do not exist.  
The highest variances explained by the East-West factor refer to the proportion of young clients 
in first treatment, non-fatal emergencies, drug deaths and prison sentences for drug law offences.  
 
Western Europe 
The high correlation between all treatment and the proportion of heroin users in first treatment 
reflects the main target population of treatment services or the development of more long-term 
substitution programmes within treatment. Unlike in Eastern Europe we find strong positive 
correlations between heroin use, IDU and drug related morbidity with arrests and seizures. 
In Western European cities, increasing mean age of first clients in treatment correlates negatively 
with non-fatal emergencies. The interpretation could be, that older users are more experienced 
users and experience reduces risk behaviour. Alternative to this “social maturation explanation” 
we might also consider a “Darwinist explanation”: younger users either quitted or died and the 
remaining older users are more resistant to risks. However, differences in drug policy, e.g. formal 
versus informal social control, could play a significant role as well. 
 
 
CITY SIZE DIFFERENCES 
 
The factor City Size has only been explored in a multiple classification analysis. Most high Eta2 
values on the City Size factor should not be surprising as many indicators relate to problem drug 
use, which in general is a typical metropolitan issue. The highest variances explained by City 
Size we find for non-fatal emergencies, incidence of Hepatitis B in IDU, drug related deaths and 
arrests related to trafficking. The relative low Eta2 values for city size with regard to drug seizures 
might indicate that seizures are not so much related to the local drug situation, but to other city 
attributes, like geographical location on international drug trade routes. 
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EAST-WEST DIFFERENCES IN INDICATOR RELATIONS 
,84 positive correlation 
-,82 negative correlation 
 
Indicator group Indicator relations WEST EAST
All treatment demand - % heroin users (first treatment) ,84
All treatment demand – Admissions to psychiatric hospitals ,86
All treatment demand – non-fatal emergencies -,82 ,52
Mean age (first treatment) - % aged < 25 (first treatment) - ,97
Mean age (first treatment) - % IDU (first treatment) ,77
Mean age (first treatment) - Non-fatal emergencies -,82
% females (first treatment) - Admissions to psychiatric hospitals ,80
% Cannabis users (first treatment) - non-fatal emergencies -,87
% heroin users (first treatment)  – Admissions to psychiatric hospitals ,91 -,54
% heroin users (first treatment) – Admissions to general hospitals -,93
TREATMENT 
% heroin users (first treatment) - Non-fatal emergencies -,84
    
Arrests for any drug law offence  - Prison sentences for drug law offences ,87
Arrests for any drug law offence  - Seizures of cocaine ,76
Convictions for drug law offences - Seizures of heroin  ,39
DRUG LAW OFFENCES  
DRUGS MARKET 
Convictions for drug law offences - Seizures of cocaine ,78
    
All treatment demand - Drug related deaths ,84
Non-fatal emergencies - Incidence of AIDS in IDU ,85 - ,21
% Cannabis users (first treatment)  - Incidence of AIDS in IDU -,86
%IDU (first treatment) – Admissions to psychiatric hospitals ,73
%IDU (first treatment) – Admissions to general hospitals -,91
%IDU (first treatment) - Non-fatal emergencies -,78 ,65
TREATMENT 
HEALTH 
%IDU (all treatment) – Admissions to general hospitals -,99 ,44
    
First treatment demand – Seizures of cocaine  ,85
First treatment demand – Seizures of amphetamines ,80
All treatment demand – Arrests for any drug law offence  ,72
All treatment demand – Convictions for drug law offences ,71
All treatment demand – Seizures of heroin   ,77
All treatment demand – Seizures of cocaine  ,76
All treatment demand – Seizures of amphetamines   ,72
Admissions to psychiatric hospitals – Convictions for drug law offences ,73
Admissions to psychiatric hospitals – Seizures of heroin  ,94
Admissions to psychiatric hospitals – Seizures of cocaine  ,93
Admissions to psychiatric hospitals – Seizures of amphetamines  ,91
Admissions to general hospitals – Arrests for drug trafficking offences  ,83
Admissions to general hospitals – Prison sentences for drug law offences -,74
Non-fatal emergencies – Arrests for any drug law offence ,69
Heroin users (first treatment) - Arrests for drug trafficking offences ,82
Heroin users (first treatment) – Prison sentences for drug law offences ,81
% heroin users (first treatment) – Arrests for drug trafficking offences -,77
% heroin users (first treatment) – Arrests for any drug law offence -,70
TREATMENT  
DRUG LAW OFFENCES 
DRUGS MARKET 
% heroin users (first treatment) – Prison sentences for drug law offences -,93
    
Incidence of Hepatitis B in IDU - Arrests for any drug law offence ,79
Incidence of Hepatitis B in IDU - Seizures of amphetamines ,74  
Incidence of AIDS in IDU - Prison sentences for drug law offences ,95
Drug related deaths – Seizures of cocaine  ,76
Drug related deaths - Seizures of amphetamines ,80
% IDU (first treatment) – Arrests for drug trafficking offences  ,88
% IDU (all treatment) – Arrests for any drug law offence ,92
% IDU (first treatment) – Arrests for any drug law offence ,94
% IDU (first treatment) – Seizures of heroin  ,80  
HEALTH  
DRUG LAW OFFENCES 
DRUGS MARKET 
% IDU (first treatment) – Seizures of cocaine  ,95
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IMPORTANCE OF EAST-WEST FACTOR 
ON INDICATOR VARIANCE 
 
,22  significant contribution to variance explanation 
  significant interaction with City Size 
 
Results of Analysis of Variance (Hierarchical) / Multiple Classification Analysis  
 Indicator 
group Indicator 1991-1997 1997 1996 
interactions 
with 
City Size 
factor 
 
valid 
cases 
       
First treatment demand ,02    112 
All treatment demand ,05    118 
Mean age (first treatment) ,08    84 
% Females (first treatment)  ,02    104 
% < 25 (first treatment)  ,37    88 
Admissions to psychiatric hospitals ,00    70 
Admissions to general hospitals ,22    64 
Non-Fatal Emergencies ,32    61 
% Cannabis users (first treatment) ,09    47 
TREATMENT 
% Heroin users (first treatment) ,04    61 
       
% IDU in first treatment ,12    55 
% IDU in all treatment ,06    53 
Incidence of Hepatitis B in IDU ,16    67 
Incidence of AIDS in IDU ,02    96 
HEALTH 
Drug related deaths ,31    120 
       
Arrests for drug trafficking offences ,15    69 
Arrests for any drug law offence  ,19    72 
Convictions for drug law offences ,17    113 
DRUG LAW 
OFFENCES 
Prison sentences for DLO ,31    68 
       
Seizures of cannabis  ,09    70 
Seizures of heroin ,24    63 
Seizures of cocaine  ,11    66 
DRUGS 
MARKET 
Seizures of amphetamines ,21    61 
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IMPORTANCE OF CITY SIZE FACTOR 
ON INDICATOR VARIANCE 
 
,22  significant contribution to variance explanation 
  significant interaction with East-West factor 
 
Results of Analysis of Variance (Hierarchical) / Multiple Classification Analysis  
Eta2 CITY SIZE Indicator 
group Indicator 1991-1997 1997 1996 
interactions 
with 
East-West 
factor 
 
valid 
cases 
       
First treatment demand ,22    112 
All treatment demand ,11    118 
Mean age (first treatment) ,03    84 
% Females (first treatment)  ,00    104 
% < 25 (first treatment)  ,00    88 
Admissions to psychiatric hospitals ,20    70 
Admissions to general hospitals ,00    64 
Non-Fatal Emergencies ,41    61 
% Cannabis users (first treatment) ,07    47 
TREATMENT 
% Heroin users (first treatment) ,14    61 
       
% IDU in first treatment ,19    55 
% IDU in all treatment ,22    53 
Incidence of Hepatitis B in IDU ,50    67 
Incidence of AIDS in IDU ,08    96 
HEALTH 
Drug related deaths ,37    120 
       
Arrests for drug trafficking offences ,30   69 
Arrests for any drug law offence  ,10   72 
Convictions for drug law offences ,05   113 
DRUG LAW 
OFFENCES 
Prison sentences for DLO ,02   68 
       
Seizures of cannabis  ,06   70 
Seizures of heroin ,00   63 
Seizures of cocaine  ,04   66 
DRUGS 
MARKET 
Seizures of amphetamines ,01   61 
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5.2 
INTERPRETATION 
(EXPERT SURVEY) 
 
 
 
METHODS OF ANALYSIS 
 
In this section we present the results of a survey among the experts of the Epidemiology Group 
about their perceptions of trends and developments in Multicity network. The survey –called the 
‘interpretation survey’- was held in March and April 1999. The main intention was to collect 
additional information to the often incomplete picture of the individual city reports. This survey 
among the experts reveals a kind of condensed summarising interpretation of the overall 
development of the drug situation in Europe and its results can be regarded as an expert 
validation measure of some of the findings of the previous analysis of indicator data.  
The survey pursued following aims: 
 to assess changes in the relative order of prevalences of individual drugs; 
 to obtain a perceptual notion of drug trends in addition to trends to be observed from data or 
as an alternative when data are not yet available; 
 to get more insight into the orientation of local drug policy as a frame of reference for 
observed and perceived trends and developments  
The survey questionnaire was distributed to 75 experts participating in the Multicity network in the 
second half of the 1990s. Due to organisational problems the experts of the Russian cities could 
not be included in the survey. 30 completed questionnaires have been returned. However, in the 
target population were many experts who in the network act or have acted as substitutes for 
others and referred to them for the response. If we account for these “doubles” the response 
increases to 55 (73%).  
The response covers 26 cities, 16 from Western Europe and 10 from Eastern Europe, including 3 
cities not participating in the Multicity data collection (Luxembourg, Bucharest, Zagreb).  
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PROBLEM DRUG USE 
 
Until 1997 the Multicity network did not collect information about estimates of problem drug use 
and with the 1998 updates only 5 cities provided an estimate.  
In the interpretation survey we had defined “problem drug users” as drug users who are in need 
of treatment. For 20 cities of the multi-city network we received an estimate. It should be 
remarked that in most cases the figure is an estimation of only one –informed- expert. The figures 
have been transformed into rates per 100.000 and are compared to the city’s figures of all 
treatment demand in 1997 or 1998.  
As in the case of other indicators, we find considerable differences in indicator values between 
the cities of the network. 
 
Estimate of problem drug use and assumed proportion in treatment, 1997-1999 
 
 
PREVALENCE 
 
Information about drug prevalence among the general population is often not available at city 
level. To a lesser extent the same holds for data about drug prevalence in the treated population. 
Based on the qualitative sections of the city reports we assume nevertheless that most experts 
have a general picture of the developments in relative importance of specific drugs used in their 
community. In the interpretation survey we therefore asked to estimate from informed experience 
rank orders of prevalence for individual drugs in the early and late 1990s, both among the general 
population and among problem drug users in need of treatment.  
The results provide some insight in developments over time and the problem aspects of individual 
drugs. We present these results as sets of “illicit pyramids”, differentiated between Eastern and 
Western Europe and between large and smaller cities. As before the split between large and 
smaller cities has been set at a population of 1 million. Substances are listed in the pyramids in 
reverse order of prevalence. The order follows the average rank order as indicated by the city 
experts. In cases of equal ranking, the substance with the greater pharmacological potency is 
ranked higher.  
A comparative look at the pyramids reveals some remarkable differences, in particular between 
the Eastern- and Western-European cities. We just point to some striking observations. 
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→ There is obviously a dramatic loss of importance of inhalants in the Eastern European cities 
in the course of the 1990s. To a lesser extent this also applies to “opium”, which in this 
context should be read as homemade opiates, at least in the general population. In the 
course of the democratisation process and the associated opening of the borders and access 
to new cultural influences, 'new' drugs have gained attractiveness and replaced previous drug 
use patterns. 
→ Apart from cannabis, different drugs seem to be of different importance in the general 
population of East and West. This variation could be blamed on different, not at least sub-
culture driven, drugs markets and the proximity to different main drug trafficking routes. For 
instance the proximity of Eastern Europe to the principal poppy-growing areas versus the 
proximity of Western Europe to the main cocaine trade routes. 
→ Generally speaking, opiates seem to be more important in the Eastern cities, whereas 
stimulating drugs –in particular cocaine- seem to be more important in the West. This is also 
reflected in the 'problem use pyramids' and the previous multiple classification analyses. The 
question remains, whether cocaine in due time will reach such a status in the Eastern cities 
as it was the case in Western Europe compared to the United States. 
 
 
Prevalence general population - Early 1990s 
EASTERN EUROPE WESTERN EUROPE rank order 
   
Crack Crack 9 
Cocaine Inhalants 8 
E c s t a s y  O p i u m  7 
Hallucinogens E c s t a s y  6 
Amphetamines Hallucinogens 5 
H e r o i n  H e r o i n  4 
O p i u m  C o c a i n e  3 
C a n n a b i s  A m p h e t a m i n e s  2 
I n h a l a n t s C a n n a b i s  1 
   
Prevalence general population – Late 1990s
EASTERN EUROPE WESTERN EUROPE rank order 
   
Crack Crack 9 
Opium Inhalants 8 
Cocaine O p i u m  7 
Hallucinogens H e r o i n  6 
I n h a l a n t s  Hallucinogens 5 
E c s t a s y  Amphetamines 4 
A m p h e t a m i n e s  E c s t a s y  3 
H e r o i n C o c a i n e  2 
C a n n a b i s C a n n a b i s  1 
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Primary drug among users in need of treatment – Early 1990s 
EASTERN EUROPE WESTERN EUROPE rank order 
   
Crack Ecstasy 9 
Ecstasy Inhalants 8 
C o c a i n e  C r a c k  7 
Amphetamines Hallucinogens 6 
Hallucinogens C o c a i n e  5 
C a n n a b i s  Amphetamines 4 
I n h a l a n t s  O p i u m 3 
O p i u m  C a n n a b i s 2 
H e r o i n  H e r o i n  1 
 
Primary drug among users in need of treatment – Late 1990s  
EASTERN EUROPE WESTERN EUROPE rank order 
   
Crack Hallucinogens 9 
Cocaine I n h a l a n t s  8 
Hallucinogens O p i u m  7 
E c s t a s y  E c s t a s y  6 
I n h a l a n t s  C r a c k  5 
C a n n a b i s  C a n n a b i s  4 
O p i u m  A m p h e t a m i n e s  3 
A m p h e t a m i n e s  C o c a i n e 2 
H e r o i n  H e r o i n  1 
 
 
→ There are also some striking observations regarding particular drugs. In the West-European 
cities cannabis is without exception the most common illicit drug. Heroin is both in the west 
and the East the number one 'problem drug'. Crack is contrary to common drug political 
discourse and media hype of minor importance in the general drug using patterns and even 
in the user groups deemed to be in need of treatment. Though, it has to be said that crack 
has achieved a slightly higher rank in the course of the 1990s in Western European cities. 
→ The 'classic' drugs of the Eastern European scene in the early 1990s, inhalants and 
homemade opiate extracts, are being replaced by heroin and amphetamines. The 
observation might even have been more prominent if the Russian experts had participated in 
the survey. The change of the 'general prevalence pyramids' in the course of the 1990s 
confirms the hypothesis that the Eastern and Western European developments within this 
phenomenological context seem to converge. 
→ A multiple classification analyses on the rank orders of the various drugs does not show 
significant differences between the smaller and larger cities with regard to drug using patterns 
in the general population. But looking at the 'problem use pyramids' we see some striking 
differences. At the beginning of the 1990s we can observe different perceptions of 'problem 
drug use', which seem to have diminished at the end of the 1990s, when the pyramids are 
looking rather equal. 
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Prevalence general population –Early 1990s 
CITIES <  1Mio. CITIES > 1Mio. rank order
   
Crack Crack 9 
Ecstasy Ecstasy 8 
C o c a i n e  O p i u m  7 
Hallucinogens I n h a l a n t s  6 
O p i u m  H e r o i n  5 
Amphetamines C o c a i n e  4 
I n h a l a n t s  H a l l u c i n o g e n s  3 
H e r o i n A m p h e t a m i n e s  2 
C a n n a b i s C a n n a b i s  1 
   
Prevalence general population – Late 1990s
CITIES < 1 Mio. CITIES > 1Mio. rank order
   
Crack Crack 9 
O p i u m  O p i u m  8 
I n h a l a n t s  I n h a l a n t s  7 
Hallucinogens Hallucinogens 6 
C o c a i n e  H e r o i n  5 
E c s t a s y  C o c a i n e  4 
Am p h e t a m i n e s  Am p h e t a m i n e s  3 
H e r o i n E c s t a s y  2 
C a n n a b i s C a n n a b i s  1 
 
Primary drug among users in need of treatment – Early 1990s  
CITIES < 1 Mio. CITIES > 1 Mio. rank order
   
Crack Ecstasy 9 
Ecstasy C r a c k  8 
Hallucinogens Hallucinogens 7 
Amphetamines C a n n a b i s  6 
C o c a i n e  I n h a l a n t s  5 
I n h a l a n t s  C o c a i n e  4 
O p i u m  Am p h e t a m i n e s  3 
C a n n a b i s  O p i u m  2 
H e r o i n H e r o i n 1 
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Primary drug among users in need of treatment – Late 1990s  
CITIES < 1 Mio. CITIES > 1 Mio. rank order 
   
Hallucinogens Hallucinogens 9 
Inhalants C r a c k  8 
C r a c k  E c s t a s y  7 
E c s t a s y  I n h a l a n t s  6 
O p i u m  O p i u m  5 
C o c a i n e  C o c a i n e  4 
C a n n a b i s  C a n n a b i s  3 
A m p h e t a m i n e s  A m p h e t a m i n e s  2 
H e r o i n  H e r o i n  1 
 
 
 
NEW AND OLD DRUGS 
 
Although the pyramids already provide an indication of emerging and disappearing drugs, we 
also asked the experts to identify which drugs have appeared (new drugs) and which ones have 
vanished (old drugs) from the cities' drug scenes. The response confirms the changes in the illicit 
pyramids and we can make the following additional observations. 
 
New and old drugs in Eastern and Western Europe in the 1990s; 
bars relative to percentage of experts labelling a drug as “new” or “old” 
 
→ In Eastern Europe most drugs other than inhalants and opium (opiate extracts) are perceived 
more or less as new drugs. Only a few however consider inhalants and opium today as old 
drugs, which implies that they have not yet disappeared from the scenes. In the West both 
ecstasy and crack are observed as new drugs, but nothing seems to have disappeared. 
WESTERN EUROPE EASTERN EUROPE
old new old new
drug drug drug drug
inhalants
hallucinogens
ecstasy
amphetamines
crack
cocaine
opium
heroin
cannabis
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→ The fact that drugs in the perception of the experts do not disappear could be hypothetically 
interpreted that as soon as substances having achieved a wider spread they hardly totally 
vanish from the cultural selection of psychoactive substances. Taking hallucinogens as an 
example: they were used to a wider extent, but limited to particular social subgroups in the 
late 1960s and early 1970s. Since then, hallucinogens have spread over the social stratum, 
over different social milieus, and have become well established in the cultural consciousness 
regarding the use of psychoactive substances. Nevertheless, hallucinogens are still not 
widely used in the general population. 
 
 
TRENDS IN INDIVIDUAL DRUGS 
 
Even at national level most countries do not yet have consistent time series to assess trends in 
the prevalence of illicit drugs among the general population. On the other hand experts in the field 
in general will have some notions about what is going on from other sources as the treatment 
system, the police, prevention activities, etc. As a next step in the fine-tuning of our assessment 
of local drug use prevalence, we asked in the interpretation survey to assign a perceived trend 
pattern to individual drugs. Again we present the results in graphic format for large and smaller 
cities and for Eastern and Western Europe separately. In the graphs the bars are relative to the 
percentage of experts who perceive the predefined trend pattern as applicable to a substance 
during the 1990s. 
As already observed before, the classic drugs of Western Europe, cannabis and heroin, seem to 
be of growing importance in Eastern Europe. Almost all city experts of Eastern Europe report up- 
or upward trends for both cannabis and heroin, compared to only half of the experts in the West. 
Similar differences can be observed with regard to amphetamines. In contrast, cocaine is typical 
for Western European cities.  
Remarkable is the parallel trend in the use of ecstasy in Eastern and Western Europe. Nearly 
without exception all cities report a still ongoing up-/upward trend. For crack, the information 
provided supports the already stated hypothesis of a minor attractiveness of this drug in 
European cities. For the majority of cities this drug has not yet appeared in the local scene on a 
noticeable scale. 
A first comparative glimpse the city size factor does not reveal major differences in the reported 
trend patterns in the 1990s. 
 
Perceived trend patterns of cannabis in the 
1990s, in Eastern and Western Europe and in 
large and smaller cities.  
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Perceived trend patterns of drugs in the 1990s  
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Perceived trend patterns of drugs in the 1990s 
 
 
EPIDEMIOLOGICAL STAGES 
 
Trend assessment might be one of the main purposes of drug monitoring systems, they give 
insufficient information about the diffusion of drug use in the community. Even when trends go up, 
drug use might still be restricted to specific groups or areas. Estimating prevalences and trends 
separately for all sorts of subgroups is quite problematic, not only because in general we do not 
have appropriate data on attributes, other than gender and age, of the drug using population, but 
also because we do not always know in advance which attributes we need to look for. 
To obtain at least some impression on diffusion of drug use, we included in the interpretation 
survey an experimental assessment question. This was placed in the context of the development 
of a meta-concept of “epidemiological stages” to describe and understand the complex indicator 
patterns of individual cities. Below we first explain this concept and then return to the results of 
the interpretation survey. 
Epidemiological stages 
In our phenomenological context 'epidemiological stages' refer to a certain distribution level of 
certain substances in the population of a given area or city. The theoretical construction of the 
epidemiological stages defined further down is closely linked to the epidemiology's original field of 
medical sociology. In line with the epidemiologists' main focus directed towards the origin and 
spread of diseases, our analyses' guiding interest is put on the social background of, and the risk 
factors associated with, the spread of the use of illicit drugs. 
The model of epidemiological stages does not provide any explanations of drug use. It should be 
seen as an attempt towards a better description of the drug use phenomenon’s developments. 
Further theoretical work will have to make it more precise to better depict drug-using situations, 
but even the actual stand of the model allows descriptions of the spread of drugs or the diffusion 
pattern of particular drugs, which make much more sense than common tendencies to label any 
rise in prevalence rates as an epidemic or threat to society. 
To take the example of the “crack-epidemic” in the United States: "The empirical evidence on 
crack use suggests that politicians and journalists have routinely used the word 'epidemic' and 
'plague' imprecisely and rhetorically as words of warning, alarm, and danger. (...) If the word 
'epidemic' is used to mean a disease or disease-like condition that is 'widespread' or 'prevalent', 
then there has never been an epidemic of crack addiction (or even crack use) amongst the vast 
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majority of Americans. (.....) An 'epidemic of crack use' might be a description of what happened 
among a distinct minority of teenagers and young adults from impoverished urban 
neighbourhoods in the mid to late 1980s" 1 
The development of 'epidemiological stages' has to be aware of the circumstance that the spread 
of psychoactive substances is -in many cases strongly- linked to limits and bounds, which in the 
first place refer to age and the social stratum. Research on risk factors of drug use and 
prevalence surveys clearly reveal a close link between certain substances and specific age-
cohorts and social-economic groups. A description of prevalence rates of different drugs is not 
imaginable without reflecting upon the age-structure and the social structure of the (main) user 
groups. Summarising the respective drug research's actual stand, the social networks -mainly 
developing along an age and socio-economic divide- of people with whom regularly contacts and 
closer relationships take place seem to be a crucial social determinant of drug using behaviour.  
A third element of the stage model consists of the geographic, regional, and local bounds, which 
are the central differentiation criterion in classical epidemiology. Apart from national differences, 
geographic differences in the spread of illicit drugs appear mainly in the form of a rural-urban 
gradient.  
The terminology we apply is illustrated and described below. 
1 Endemic: the spread of the particular psychoactive substance is strongly limited to 
certain age-cohorts, socio-economic groups AND geographic boundaries. 
2 Endemic-epidemic: the trend indicates an exceeding of the use of the substance over 
age-, social-, OR geographic-boundaries 
3 Epidemic: the usage of the substance is spreading over different age-cohorts, socio-
economic groups OR geographic areas 
4 Epidemic-pandemic: the spread of the particular substance is not restricted (anymore) 
to clearly definable age-cohorts, socio-economic-groups AND geographic areas 
5 Pandemic: the particular substance is strongly spreading over different age-cohorts, 
socio-economic groups AND geographic areas. 
                                                     
1 Reinarman, C., Levine, H.G. (1997): The Crack Attack: Politics and Media in the Crack Scare. In: Reinarman, C., Levine, H.G. 
(eds.): Crack in America. University of California Press, Berkeley/Los Angeles/London: 33f. 
1    2   3  4   5 
exceeding of bounds 
    age, social, socio-economic, and 
geographic bounds 
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It is obvious that stages 1 to 5 are associated with increasing prevalence. In the previous 
paragraph we introduced a five-point ordinal scale to describe drug use trends. This scale is 
applicable to all epidemiological stages. 
As an example, referring again to the crack 'outbreaks' during the mid and late 1980s in the USA. 
At the beginning there was a quick rise in the usage of crack observable within narrow socio-eco-
nomic boundaries linked to ethnic minorities and juvenile age-cohorts and restricted to 
geographical local areas or districts. This could be described as an endemic situation with an 
upward-trend. Since then, crack has reached the endemic-epidemic stage in some countries but 
it is worldwide still far away from an epidemic situation. 
It's getting obvious that different drugs could and normally do take up different epidemiological 
stages with varying developmental trends at the same time. We can, for example, observe in 
some European countries a stable heroin-using situation on an endemic stage running parallel to 
an upward trend on an epidemic stage of synthetic drugs. 
A clear upward or downward trend could indicate a transition into another (higher or lower) stage. 
Thus, ups and downs in prevalence rates are 'initial' observations, which give cause for deeper 
analyses. As already indicated, this concept of epidemiological stages is of descriptive rather 
than explanatory quality. Closer analyses going beyond the level of describing diffusion patterns 
are necessary to get insights into the dynamic of epidemiological changes by revealing relevant 
background variables concerning those identified transition processes. Taking up a lower or 
higher epidemiological stage could - generally speaking - explained as a (sub-) cultural reflex due 
to new fashion styles, political movements, trends in the spirit of the age, in the leisure time 
industry etc. Thus, exploring the background forces of epidemiological transition processes, of 
the dynamic of diffusion patterns requires an analytical reflection upon (sub-) cultural and socio-
economic developments and changes. 
The reasons for epidemiological changes could ideally be explored according to theoretical 
constructs on the phenomenon of deviance as we do find them in sociology and especially in the 
field of criminology. The basic theoretical assumption is that deviant behaviours - such as drug 
use – resemble infectious diseases and are spread through peer contacts and influences. We 
could find a lot of empirical evidence for this assumption of a peer-group based spread referring 
to the usage of drugs in various studies: "People who come in contact with many people are 
apparently not only confronted more often with positive definitions of drug use, they also have 
greater opportunities to use drugs" 2. Though, the influence of the peer group seems to vary with 
age. Especially in younger age cohorts the peer association seems to significantly impact drug 
using behaviour. 
The starting point of these theoretical models, named threshold model, critical-mass model or 
contagion model, is the idea of critical levels of incidence of a phenomenon in populations. If 
incidence stays below this point, the prevalence tends to gravitate toward some relatively low-
level equilibrium. But if incidence reaches the critical point, the process of spread can explode. In 
other words, an epidemic may occur, raising the incidence to equilibrium at a higher level. In this 
sense we could say that the epidemiological stages of our model represent different equilibrium 
levels. 
Taking up the epidemiologists’ language we also could speak of a 'tipping point', the point at 
which the usage of a drug can either turn into a serious public-health problem, or, in the case of 
incidence running below the tipping point or critical point, into a phenomenon remaining restricted 
to smaller user circles causing no striking social and health problems. Thus, we could speak with 
regard to our model of a turning point, the point at which the trend of the drug use incidence runs 
towards a higher or lower epidemiological stage.  
It should be remarked that the epidemiological dynamic of incidence running below or above a 
critical, turning point is non-linear: If the level of the snow in the Alps reaches a critical mass the 
risk of avalanches exponentially rises. But it depends on many other factors if the snow will 
avalanche down. The same applies to drugs. A wider spread of drug use is influenced in a large 
variety of ways by various factors such as, to name just some examples, subculture and youth 
culture developments (and the herewith associated leisure industry), occupational, and socio-
economic structure, prevention programmes, etc.  
                                                     
2 Reuband K.-H. [1992] Der Mythos vom einsamen Drogenkonsumenten. Kontakte zu Gleichaltrigen als Determinanten des 
Drogengebrauchs (The Myth of the Lonely Drug User. Interpersonal Contacts with Peer as Determinants of Drug Use). In: Sucht, 
3: 160-172 
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Assessment of diffusion patterns 
One of the main tasks of the 3rd Multi-City Study should be the interpretation of trends and 
developments, aiming at a notion or impression of possible critical points and the epidemiological 
dynamic of the drug use phenomenon. However, with regard to the criteria listed above, in 
particular those related to geographic and socio-economic bounds we have at present only very 
limited information available. Therefore, an identification of epidemiological stages can only be 
based on the respective views and estimations of the Epidemiology Group as an expert panel. 
Within this context we have asked the experts in the interpretation survey to mark for each drug 
listed which of the epidemiological stages as described above applies best to the situation in their 
city in the late 1990s. 
To avoid a priori confusion, we didn’t label the stages in the questionnaire, but only provided the 
qualitative description of each stage. 
The survey results are presented in the table below. It should be remarked that the information 
can only be seen as a first tentative approach, as the experts responding did not necessarily 
based their views on the same notions. For reasons of simplification average values of the five 
point stage scales have been calculated in order to assess the ‘stage’ of each drug in either 
Eastern or Western Europe. 
 
Diffusion pattern Drug 
Stage 1 Stage 2 Stage 3 Stage 4 Stage 5 
EAST      Cannabis 
WEST      
EAST      Heroin 
WEST      
EAST      Opium / opiate 
extracts WEST      
EAST      Cocaine 
WEST      
EAST      Crack 
WEST      
EAST      Amphetamines 
WEST      
EAST      Ecstasy 
WEST      
EAST      Hallucinogens 
WEST      
EAST      Inhalants 
WEST      
 
Apart from cannabis, the experts perceive the use of the specified drugs as being mainly 
restricted to particular age cohorts, social groups and neighbourhoods. Though it has to be said, 
that some of the substances have taken up already the epidemiological stage number 2, which 
signalises a certain extension of existing age and social boundaries.  
This summarised finding is more or less in line with the findings of general and school population 
surveys and reflects common findings in drug research, which identifies the use of illicit drugs as 
a typical juvenile phenomenon. That cannabis, cocaine and ecstasy take up a higher stage in the 
Western cities, and opium/opiate extracts a higher stage in the Eastern cities is not surprising and 
supported by the results of the multiple classification analyses before.  
According to our first analyses, the city-size split doesn't reveal striking differences. The spread of 
the use of the various substances does not differ significantly between larger and smaller cities. 
Further analysis might link diffusion patterns with the trend patterns. This might give an indication 
whether a drug is going to reach a higher epidemiological stage or is to settle on a lower stage. 
Based on the perceived trends discussed before, it can for example be expected that cannabis in 
the Eastern European cities will reach the higher epidemiological stage which has already been 
observed in Western European cities. 
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GENERAL LOCAL DRUG SITUATION 
 
Combining our notions about epidemiological stages with indicator data related to interventions 
(treatment, police) and information about actual or perceived orientations of drug policies and 
interventions might allow us to identify the problem level of the drug phenomenon in individual 
cities. 
In the interpretation survey we presented the experts five levels of problem situations and asked 
them to name cities as examples for each level, based on their subjective impressions from the 
city reports of the Multicity network and the “tour de table” discussions at the meetings of the 
Epidemiology Group during the 1990s. The experts could name any of the 42 cities that 
participated in the network at any time during the 1990s.The response results in the informed 
expert impression listed in the table below.    
 
Responses relating to: 
General developments in the 1990s 
(n=number of different cities mentioned) EASTERN 
EUROPE 
WESTERN 
EUROPE 
Increasing drug problems; situation out of intervention 
control or developing out of control (n=12) 19 6 
Increasing drug problems; low level of control or not (any 
more) matched by intervention control (n=13) 20 8 
Increasing drug problems; situation remains largely under 
intervention control (n=15) 1 32 
Decreasing drug problems (n=8) -- 15 
No (serious) drug problems yet (n=7) 8 4 
 
The results again confirm the East-West differentiation we considered in our analysis. The drug 
situation in Western European cities is perceived to be largely under control of health, police and 
justice interventions, accompanied by a tendency of decreasing problems. On the other hand, the 
situation in Eastern European cities is perceived as being largely out of control with an increase 
of drug problems.  
It should be noted however that there also more cities in Eastern Europe than in Western Europe 
mentioned to have no serious drug problems yet. 
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